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ABSTRACT 
 
 
 
Environmental mycobacteria are a group of human and animal pathogens that have 
significant impacts on the morbidity and mortality of humans. The prevalence of 
pulmonary disease due to environmental mycobacteria is increasing. This growth is 
due to increased identification of mycobacteria as pulmonary pathogens, 
improvements in methods of detection with culture, as well as an ageing 
population. Exposure is also likely to be responsible, as the organisms have been 
isolated from environmental sources such as water, biofilms, soil and aerosols. 
Humans are exposed to mycobacteria in water through drinking, swimming and 
bathing. Aerosols generated during these activities can be inhaled, and water can 
be aspirated when swallowed. Mycobacterium kansasii from drinking water 
samples have been linked to outbreaks of pulmonary disease. However, it is not 
clear if the organisms found in water samples are the same as those that cause 
disease in humans. 
 
From this study we were able to successfully type both human and environmental 
strains of M. kansasii. ITS strain types I, IV and V were found among the QLD patient 
isolates and Brisbane Water isolates. Newer typing methods delivered better strain 
differentiation than ITS-REA, however they have limitations. Municipal water in 
Brisbane is unlikely to be the source of infection for patients with M. kansasii 
disease. However, water contamination with M. kansasii cannot be excluded from 
other areas associated with mining and industry. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Background 
 
Non-tuberculous mycobacteria (NTM) are opportunistic pathogens, and are a major 
cause of pulmonary and extra-pulmonary disease in humans. They are commonly 
isolated from environmental sources and are not considered to be transmitted by 
person-person contact, unlike their relative Mycobacterium tuberculosis (Griffith et 
al. 2007). NTM don’t always cause significant disease in humans, and their presence 
is often regarded as colonisation/contamination unless there are clinical and 
radiological features to help prove disease. Colonisation can be defined as a 
migration of microorganisms successfully creating a community in a natural 
environment where they can thrive and survive such as the human pulmonary 
system. Contamination is seen as this colonised community creating an unwanted 
presence in any natural environment, hence why these terms have been used 
interchangeably. 
 
Currently there are more than 150 species of NTM described in the literature 
(Tortoli 2006). Molecular techniques have improved significantly recently, resulting 
in an increase of the identification of new species. Presently, the American Thoracic 
Society and Infectious Disease Association of America (ATS/IDSA) have treatment 
recommendations for only 20 species of NTM (Griffith et al. 2007). However, 
treatment may not be required for all isolates. From the most recent figures 
published in Queensland, significant public health notifiable NTM disease has 
increased from 2.2 (1999) to 3.2 (2005) per 100,000 population (Thomson 2010). 
Given that the incidence of NTM is increasing in an ageing population (Griffith et al. 
2007), the importance of further work in establishing the source of this increase is 
critical. Looking particularly at M. kansasii, it has been hypothesised that the source 
is environmental as organisms have been previously isolated from tap water 
sources (Engel et al. 1980). No definitive link has been established to conclusively 
prove that water is the source of human disease. 
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1.2 Context 
 
The major focus of this study is to identify the genotypes of M. kansasii found in 
patients and potable water samples from Brisbane and throughout Queensland, 
Australia. A problem area of research is the lack of an assay that can produce an 
accurate strain type in a clinical laboratory that is cost and time effective. Also in 
Queensland as well globally, there is a lack of information regarding M. kansasii 
infections with respect to the prevalence in the environment and linking this to 
causing disease in humans. We hypothesise that newly developed DNA-based 
genotyping methods will enable us to characterise and differentiate clinically and 
environmentally sourced strains of M. kansasii. 
 
1.3 Study Aims 
 
There are two main aims with the following objectives: 
 
Aim 1 – To genotype M. kansasii isolates using new and existing genotyping 
methods 
Objective   1.1   –   Apply   the   DiversiLab   method   to   genotyped   clinical   and 
environmental M. kansasii strains 
Objective 1.2 – Genotype clinical and environmental M. kansasii strains using an 
Internal Transcribed Spacer Region and Restriction Enzyme analysis (ITS-REA) 
method 
Objective 1.3 – Develop and apply High Resolution Melt Analysis to genotyped 
clinical and environmental M. kansasii strains 
 
Aim 2 – To compare the strain genotypes of M. kansasii isolates from clinical 
samples to those obtained from Brisbane water and patient home water samples 
Objective 2.1 – Compare the discriminatory capability of each genotyping method 
Objective 2.2 – Correlate the clinical M. kansasii strain genotypes to strain types 
from the patient home and Brisbane water samples 
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1.4 Significance and Scope 
 
Currently worldwide, there are at least seven M. kansasii strain types identified 
using the established typing schemes for this species. Exhaustive typing has been 
done on type I isolates producing many subtypes, however, questions remain 
including: are they all pathogenic? Are these pathogenic strains only recovered 
from humans or are they found in the environment as well? Knowing which strain 
type the patient has may have an impact on patient therapy (Picardeau et al. 1997). 
Identifying the particular type strain of M. kansasii the patient has may help a 
clinician in managing the patients’ infection e.g. the virulence of particular strains 
may affect the decision to treat. Treatment is a lengthy course of anti-tuberculous 
drugs described in detail in section 2.1.2. 
 
The reservoir for M. kansasii in the environment is still poorly understood and a 
conclusive relationship between water exposure and infection has not been proven. 
This study was the first of its kind in Australia where both clinical and water isolates 
were compared at the same time. The main purpose of this study was to determine 
the strain similarities of environmental and clinical M. kansasii isolates. 
 
 
There is much to discover with regards to M. kansasii strain types as there have 
been only a handful of papers published specifically on M. kansasii. There is 
literature available on type I strain of M. kansasii but very little is known about 
strain types II, III, IV, V and VI. This begs the question of whether all strain types can 
cause disease like the most commonly reported type I strain. Considering the 
recent progress in molecular typing methods, there is a justification to apply these 
methods to characterise M. kansasii strains accurately. Previous methods are very 
time consuming, difficult to perform and costly. For a routine diagnostic laboratory 
setting, rapid and cost-effective methods are vital. 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Mycobacterium kansasii and its clinical presentation 
 
2.1.1 M. kansasii disease 
 
M. kansasii is the fourth most common Mycobacterium species isolated in 
Queensland (Thomson 2010). M. kansasii often presents as pulmonary disease 
however it can cause disseminated disease in immunosuppressed humans (Griffith 
et al. 2007). 
 
Up to 60% of pulmonary isolates identified as non-tuberculous mycobacteria (NTM) 
are not considered responsible for disease (Thomson 2010). It is believed that some 
patients are colonized by these bacteria, with little or no impact on the host. Many 
other isolates are considered contaminants from either patient or laboratory 
(Falkinham 1996). It is important to differentiate NTM from its relative M. 
tuberculosis, as NTM can clinically present like tuberculosis (TB). Unlike TB, NTM’s 
are considered non-contagious (Falkinham 1996).  Figure 1 shows a comparison of a 
normal X-ray to NTM diseased lung (Figure 2), which has increased opacity in the 
right upper lobe as indicated by the arrow. 
 
   
FIGURE 1: NORMAL CHEST X-RAY. 
IMAGE: IWONA GRODZKA - NPS.ORG.AU 
FIGURE 2: PATIENT WITH M. KANSASII LUNG DISEASE. IMAGE 
FROM: (ERASMUS ET AL. 1999) 
 
M. kansasii not only causes pulmonary disease, it is also associated with 
disseminated disease. M. kansasii is the second most frequent NTM that causes 
disseminated disease in patients with Human Immunodeficiency Virus/Acquired
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Immune Deficiency Syndrome (HIV/AIDS) (Horsburgh et al. 1989). Determining the 
significance of NTM isolation in any patient is difficult and requires a combination of 
laboratory, clinical and radiographic criteria (Griffith et al. 2007). Because of the 
high level of difficulty in diagnosing NTM disease, a Special Interest Group in the USA 
developed the American Thoracic Guidelines: An official ATS/IDSA statement: 
diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases (Griffith 
et al. 2007). 
 
Table 1 below shows the criteria required for diagnosing NTM lung disease. Table 2 
demonstrates the strength shown for an accurate amount of evidence for a correct 
diagnosis. 
 
TABLE 1: CRITERIA FOR NTM LUNG DISEASE DIAGNOSIS 
 
Adapted from (Griffith et al. 2007) 
 
TABLE 2: THE STRENGTH OF RECOMMENDATION BASED ON QUALITY OF EVIDENCE 
Categories Reflecting the Strength of Each Recommendation for or against Its Use 
Category Definition 
A 
B 
C 
Good evidence to support a recommendation for use 
Moderate evidence to support a recommendation for use Poor 
evidence to support a recommendation for or against use 
Grades Reflecting the Quality of Evidence on Which Recommendations are Based 
Category Definition 
Clinical (both required) 
1. Pulmonary symptoms, nodular or cavitary opacities on chest radiograph, or a high-resolution computed 
tomography scan that shows multifocal bronchiectasis with multiple small nodules (A, I)* 
AND 
2. Appropriate exclusion of other diagnoses (A, I) 
Microbiologic 
1. Positive culture results from at least two separate expectorated sputum samples (A, II). If the results 
from (1) are nondiagnostic, consider repeat sputum AFB smears and cultures (C, III). 
OR 
2. Positive culture result from at least one bronchial wash or lavage (C, III) 
OR 
3. Transbronchial or other lung biopsy with mycobacterial histopathologic features (granulomatous 
inflammation or AFB) and one or more sputum or bronchial washings that are culture positive for 
NTM (A, II) 
4. Expert consultation should be obtained when NTM are recovered that are either infrequently 
encountered or that usually represent environmental contamination (C, III) 
5. Patients who are suspected of having NTM lung disease but do not meet the diagnostic criteria should be 
followed until the diagnosis is firmly established or excluded (C, III) 
6. Making the diagnosis of NTM lung disease does not, per se, necessitate the institution of therapy, which 
is a decision based on potential risks and benefits of therapy for individual patients (C, III) 
8 
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Adapted from (Griffith et al. 2007) 
 
2.1.2 Treatment of M. kansasii disease 
Current practice for treatment of this infection is a combination therapy of three 
different antimicrobials for a period of 12 to 18 months or until culture negative 
after 12 months of treatment (Griffith et al. 2007). According to the current 
guidelines, the regiment consists of: daily isoniazid (300mg/d), rifampicin 
(600mg/d) and ethambutol (15mg/kg/d). If rifampicin resistance is detected in the 
patients’ isolate, a change in the regime is needed for a remission status. A three 
drug combination regimen is recommended based on susceptibilities including 
clarithromycin or azithromycin, moxifloxacin, ethambutol, sulfamethoxazole, or 
streptomycin (Griffith et al. 2007). Like all drugs, there are side-effects and these 
particular agents can cause serious effects such as ocular toxicity and permanent 
liver damage (Yee et al. 2003). Patients diagnosed with M. kansasii require 
specialised physicians to monitor treatment progress as treatment failures can lead 
to drug-resistance (Ahn et al. 1981). 
 
 
2.1.3 Environmental “sources” of M. kansasii 
 
Many NTM’s are free-living saprophytes that have been recovered and isolated 
from a varied range of environments, including water, soil, dust, and aerosols 
(Falkinham 2002). McSwiggan and Collins were the first to report the isolation of M. 
kansasii from tap water in England in 1974 (McSwiggan et al. 1974). Engel, et al. 
(Engel et al. 1980) followed by publishing the first in-depth study determining the 
presence of M. kansasii in water from Rotterdam, The Netherlands. The results 
found a high number of positive isolations from taps in older buildings rather than 
newer establishments and only found one positive culture from mains water supply. 
Falkinham summarised work previously published and stated that M. kansasii is 
commonly found in urban areas rather than in regional districts (Falkinham 1996). 
I 
II 
 
 
III 
Evidence from at least one properly randomised, controlled trial 
Evidence from at least one well-designed clinical trial without randomisation, from cohort 
or case-controlled analytic studies (preferably from more than one centre), from multiple 
time-series studies or from dramatic results in uncontrolled experiments 
Evidence from opinion of respected authorities, based on clinical experience, descriptive 
studies, or reports of expert committees. 
9 
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This inference was based on Anh, et al. and Wolinsky’s research from the 1970’s 
(Ahn et al. 1979; Wolinsky 1979). A long-term study testing for M. kansasii in tap 
water found that it was isolated intermittently explaining why some groups had 
difficulty in isolating this organism (Collins et al. 1984). 
 
 
2.2 Methods used for culturing and identification of M. kansasii 
 
2.2.1 Culturing techniques 
 
Culturing and identification techniques have evolved over the last 100 years. Egg 
based solid medium (Lowenstein-Jensen media - BD) and liquid media (BACTEC™ 
MGIT™ 960 Mycobacterial Detection System – BD) methods have now replaced 
mice models and serum methodologies (Idigoras et al. 2000). M. kansasii grows 
best at 370C but can also grow at 320C. These organisms are slow growers and the 
growth rate in liquid culture takes from one-three weeks whilst solid culture is four- 
six weeks (Griffith et al. 2007). 
 
 
 
2.2.2 Identification techniques 
 
There are many ways of identifying Mycobacterium, from the early days of 
biochemical tests (Tsukamura 1981) to the more recent developments of 
Polymerase Chain Reaction (PCR). There have been numerous advances in NTM 
genetic research, in particular, with regards to determining the best genomic region 
for differentiating NTM strains. There are numerous journal articles published in 
this field, but the most accepted regions used for identifying NTM, are 16S rRNA 
(Abed et al. 1995; El Amin et al. 2000), and Heat Shock Protein hsp65 (Devallois et 
al. 1997; Kim et al. 2005). 16S rRNA is a suitable target for identification of bacteria, 
as it is highly conserved yet variable enough to provide differentiation. There are 
hypervariable regions A and B outside the 16S rRNA region (El Amin et al. 2000), 
which provide sufficient variability to allow these regions to be used for the 
identification of Mycobacterium sp. 
10 
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Heat shock proteins, or HSP, are a class of proteins with related functions. Their 
expression increases when cells are exposed to elevated temperatures or other 
stress. Heat shock proteins help protect other proteins from heat stress (Campbell 
2009). This response to heat stress can also be seen in heat-stressed animals and 
microorganisms (Campbell 2009). HSPs can be found in almost all living organisms, 
ranging from bacteria to humans (Campbell 2009). hsp65 is a bacterial protein that 
has been found to be unique to Mycobacterium sp. as previously discussed by 
(Shinnick et al. 1988). Some strains of M. kansasii have identical 16S sequences as 
M. gastri; hence hsp65 is used to differentiate these strains further. Figure 3 depicts 
a typical structure of the hsp65 gene. 
 
 
 
 
FIGURE 3: DIAGRAMMATICAL REPRESENTATION OF THE HSP65 GENE. THERE ARE THREE SITES THAT HAVE BEEN USED TO 
SPECIATE MYCOBACTERIUM SP. (KIM ET AL. 2005). THE BLUE ARROW INDICATING THE 441 BASE PAIR (BP) REGION OF 
THE GENE IS THE MOST COMMONLY USED PART OF THE GENE UTILISED FOR SPECIATION. 
 
 
 
2.3 Strain types and genotyping methods used for M. kansasii 
 
2.3.1 Current genotyping methods 
 
A reproducible typing technique with strain level resolution is essential when 
comparing patient and environmental isolates (Pfaller et al. 2007). Strain typing 
over a period of time is important as the rate of genomic evolution of M. kansasii is 
not known.  There has been a long progression of genotyping methods used to type 
M. kansasii strains. 
 
 
The first method for strain differentiation of M. kansasii was published in 1975 by 
Engel and Engel described the use of phage typing as an approach to type M. 
kansasii (Engel 1975).   From 1975 to 1997, no studies were published showing 
 
11 
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improvement in strain differentiation. Picardeau, et al. was the first to evaluate 
many newly described DNA-based techniques for the identification and strain typing 
of M. kansasii (Picardeau et al. 1997). The methods investigated included: analysis 
of restriction fragment length polymorphisms (RFLPs) with the major polymorphic 
tandem repeat (MPTR) probe and the insertion sequence (IS1652) probe, Southern 
blot hybridisation, pulsed field gel electrophoresis (PFGE), amplified fragment 
length polymorphism (AFLP) analysis, PCR restriction analysis (PRA) and AccuProbe 
Gen-Probe (Hologic®, USA) identification (Picardeau et al. 1997). Overall, results 
were correlated between the different typing methods. However, two of these 
methods could only identify two out of the five M. kansasii strain types (IS1652 is 
only present in strain type II & III and AccuProbe could not identify strain type II or 
IV). 
 
Alcaide, et al. (1997) published their study using the same techniques as Picardeau 
but performed additional assays, these included: hsp65 PCR followed by restriction 
fragment length polymorphism (PCR-RFLP) analysis using enzymes BstEII and HaeIII 
with separation by agarose gel electrophoresis (Telenti et al. 1993), gyrA intein 
enzyme digest as well as AccuProbe Gen-Probe (Hologic®) identification. After this, 
sequencing of the 16S-23S rRNA intergenic spacer (ITS) region of all isolates and 
PFGE was performed on the type I isolates as per protocol (Burki et al. 1995). 
 
Iinuma, et al. (1997) was next to publish and used a unique technique to type M. 
kansasii not previously done by either Picardeau or Alcaide. They used Large- 
Restriction-Fragment analysis (LRF) and investigated the typeability, reproducibility 
and the discriminatory power of the method when applied to this species. They 
used five restriction enzymes, eventually choosing the restriction enzyme that gave 
the greatest discrimination (VspI). The isolates were run on PFGE to generate 16 to 
21 fragments. The VspI enzyme yielded 21 fragments. These results showed a 
better discrimination than the previous methods used by Picardeau and Alcaide. 
 
Roth, et al. described a novel typing method using the 16S-23S rRNA spacer region 
as the target (Roth et al. 2000). HaeIII and CfoI restriction enzymes were used to 
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visualise the fragments using RFLP and agarose gel electrophoresis. This method 
was successful at discriminating Mycobacteria that previously could not be 
separated. This method can not only be used to type M. kansasii but also can 
speciate other commonly isolated Mycobacteria such as M. intracellulare, M. avium, 
etc. (Roth et al. 2000). 
 
Gaafer et al. (2003) took a different approach and published an evaluation of the 
modifications of the AFLP technique (Gaafar et al. 2003). Gaafer focused on the 
type I M. kansasii isolates, discriminating type I strain with a streamlined AFLP 
technique using a single enzyme, adaptor and primer. This method revealed a high 
level of heterogeneity between the subspecies that was thought to be clonal. 
Following on from Gaafer, Zhang et al. (2004) performed PRA of the hsp65 gene and 
PFGE on isolates from USA (Zhang et al. 2004). PRA matched the five strain types 
described in previous studies (Alcaide et al. 1997; Picardeau et al. 1997). 
 
The articles mentioned within this literature review, discuss briefly the clinical 
relevance of the different strain types of M. kansasii. Type I has been isolated most 
commonly world-wide and is also thought to be the strain type that causes disease 
(Griffith et al. 2007). The proportion of the other known strain types vary between 
countries and this may reflect different environmental conditions that exist (Wu et 
al. 2009). A definitive relationship has not been established yet between strain 
types to disease (disseminated vs pulmonary). It is assumed that type I causes 
disease but this could be due to being the most common isolated type (Griffith et al. 
2007). The relationship between antibiotic susceptibility and strain types is also not 
fully understood. Susceptibility testing is not routinely performed as a set regime 
for treatment is used and only further investigated if no clinical improvement is 
seen after therapy (Griffith et al. 2007). The isolates that have had strain typing and 
susceptibility testing done concurrently, have not been informative in defining a 
clear answer (Wu et al. 2009). 
 
Looking at retrospective studies, Taillard et al. (2003) completed a survey in 
Switzerland using clinical implications rather than evaluating molecular techniques 
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(Taillard et al. 2003). Strain typing was performed using PCR-restriction enzyme 
analysis of hsp65 as previously described by (Alcaide et al. 1997). No data analysis 
was demonstrated or provided in the article. Santin, et al. (2004) performed a 
retrospective genotyping study in Catalonia, Spain and found that 97.8% of M. 
kansasii were type I isolates (Santin et al. 2004). The isolates were first identified 
using phenotypic methods and species confirmation by the AccuProbe assay. 
Following identification, typing was performed using PCR-RFLP analysis of the hsp65 
gene as described in Alcaide et al. (1997). Their results showed only two isolated M. 
kansasii strain types, however this study focused on the incidence of M. kansasii 
within HIV and non-HIV populations rather than genotyping isolates. 
 
da Silva Telles, et al. (2005) performed antibiotic susceptibilities as well as PRA- 
hsp65 on M. kansasii clinical isolates in Brazil (da Silva Telles et al. 2005). Of the 106 
isolates that were typed, 104 were type I, whilst type II and type III had one isolate 
each, as determined by Telenti’s method (1993). This paper places more emphasis 
on antibiotic testing rather than strain typing but did make a note that the 
genotypic characterisation of the isolates did not correlate well with clinical disease. 
It was also mentioned that antimicrobial MIC values identified could not correlate 
whether the patient would succeed in remission from the infection. From  the 
strains used in the study, only two isolates were not type I strain and no discussion 
was provided to inform if the two isolates had a unique sensitivity profile. No data 
analysis or tabulated statistics was provided for the typing of the isolates. 
 
Chimara, et al. (2004) performed a similar study to Santin, et al. (2004). They 
identified 189 isolates of M. kansasii and performed PRA-hsp65 using the restriction 
enzymes BstEII and HaeIII (Chimara et al. 2004).  Of the 189 isolates, 182 were type 
I, one type II, one type III and five were other Mycobacterium sp. This retrospective 
study focused on HIV status, similar to Santin et al. (2004). A cause for concern in 
the accuracy of initial identification was that only phenotypic methods such as cord 
formation visualised microscopically using Ziehl-Neelsen staining was used. There 
may have been other species that could have been missed or misidentified using 
such a crude technique, therefore questioning the validity of their results. 
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Further retrospective studies were published in foreign languages where the 
abstract was only available in English. The details of these studies are as follows: 
Leal Arranz, et al. (2005) carried out a clinical and epidemiological retrospective and 
prospective study of M. kansasii in the metropolitan area of Bilbao, Spain (Leal 
Arranz et al. 2005). They discovered that the majority of the isolates were genotype 
I (98.5%) and amongst type I isolates, eight clones were found. Of these eight 
clones, 1 and 3 were the most common. The typing methods and all genotypes 
were not described. Jiménez-Pajares, et al. (2005) studied the phenotypic and 
genotypic characteristics of M. kansasii over a four-year period in Spain (Jimenez- 
Pajares et al. 2005). The genotypic characteristics where evaluated using PRA- 
hsp65 and restriction enzyme digestion with BstEII and HaeIII using Telenti’s 
method (Telenti et al. 1993). They identified 5 out of 6 of the described genotypes 
with 86.6% strains identified as type I. They concluded that together conventional 
and molecular methods accurately identify atypical isolates. 
 
Mimura (English abstract only, published in Japanese) investigated the 
epidemiology of M. kansasii infections in Okayama Prefecture, Japan, to consider 
the mode of infection using PFGE (Mimura 2005). Isolates were typed using the 
restriction enzyme VspI as described by Iinuma et al. (1997). Tap water from five 
industrial companies from the same area was collected and cultured to investigate a 
potential source of infection. The M. kansasii isolates were clustered into groups IV 
and V but the tap water isolates could not be characterised by PFGE. They 
concluded that the source was living as a common environmental source. The full 
text of this manuscript would have been useful to assess the strain relatedness 
between clinical and water isolates, as the translation of the conclusions in the 
abstract was not informative. These three abstracts made it difficult to derive 
definitive conclusions. The full text would be needed to review the typing 
techniques and analysis. 
 
Yoshida, et al. published a research paper (Yoshida et al. 2007) and a review paper 
(Yoshida et al.  2011)  on M. kansasii molecular epidemiology, (both articles in
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Japanese). The research paper has an abstract summary in English where it was 
stated that PCR-PRA-hsp65, ITS and 16S-23S sequencing, PFGE, RFLP with the MPTR 
and IS1652 probes were used in their study. Results briefly state that of the 174 
isolates tested, 170 were classified as type I, two belonged to type II and one each 
were type IIb and type VI. The review paper’s abstract briefly discussed M. kansasii 
and the epidemiological trends of disease in Japan. Without a full translation, a 
comparison to the other Japanese studies to correlate results within the country 
was not possible. 
 
Wu, et al. (2009) published a clinical review, antibiotic profiles and molecular 
analysis of M. kansasii isolates in  Taiwan  (Wu et al.  2009). Restriction enzyme 
digestion PFGE was performed as previously described by (Zhang et al. 2004). They 
observed nine different PFGE patterns with cluster I being the most common. Their 
results correlated well with Brazilian investigators, but differed to other Western 
nations. The results are displayed effectively indicative of a robust study. 
 
More recently, Sajduda, et al. (2012) used PRA-hsp65 using capillary electrophoresis 
with previous identification using LiPA assay (INNO-LiPA MYCOBACTERIA, 
Innogenetics, Belgium) (Sajduda et al. 2012). This is a relatively new approach to 
strain typing, more rapid and accurate to perform, but it is costly and out of reach 
of most laboratories. This group also used tap water samples in their study along 
with human isolates and one animal isolate. Of the 27 strains tested PRA type I 
dominated with 11 clinical strains, the reference strain and one environmental 
isolate. Of the remaining 15 isolates, PRA type II included four human, two 
environmental and one animal strains; type III included five environmental strains, 
type IV included two environmental strain; and one type V environmental strain 
was identified. This paper combined both old and new techniques and showed that 
both could be reproduced and used for other Mycobacterium sp. as well. 
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2.3.2 Current literature on Diversilab and High Resolution Melt Analysis 
 
Diversilab as a tool for strain typing has appeared in the literature only the last eight 
years. Specifically, there have been fourteen papers published where this method 
has been applied to both TB and NTM. 
 
Cangelosi, et al. (2004) evaluated the rep-PCR method using M. tuberculosis and M. 
avium species (Cangelosi et al. 2004). Both species results correlated with previous 
strain typing methods described in the paper. Freeman, et al. (2005) used the rep- 
PCR technique as a confirmation of the Multi-locus repeat units (MIRU) method 
(Freeman et al. 2005). They described Diversilab as a useful tool to show clusters as 
a quick and relatively cheaper alternative to MIRU. Ashworth, et al. (2008) 
published similar results to Freeman, et al. (2005) in which they depicted the rep- 
PCR method as a reliable detection method for visualising TB outbreaks with a 
better turnaround time compared to MIRU (Ashworth et al. 2008). Al-Hajoj, et al. 
(2010) used rep-PCR as a diagnostic tool to determine the evolution of TB strains in 
a particular patient in response to treatment (Al-Hajoj et al. 2010). Jang, et al. 
(2011) compared RFLP and Diversilab methods (Jang et al. 2011). They found that 
both methods are reproducible; however, Diversilab showed greater diversity 
amongst previously recognised clonal clusters. All papers showed a good 
discriminatory power compared to the methods currently accepted as the standard 
for TB typing. 
 
Currently, there have been nine papers published using Diversilab as a strain typing 
method for NTM. Wang, et al. (2008) used rep-PCR to characterise a pseudo- 
outbreak of M. paraffinicum in a hospital (Wang et al. 2008). Gira, et al. (2004) 
used rep-PCR to confirm a patient’s infection with the bacteria M. mageritense 
originated from a foot-bath salon (Gira et al. 2004). Marshall, et al. (2011) used 
Diversilab to link municipal drinking water as the source of infection for patients 
with M. lentiflavum disease (Marshall et al. 2011). There are six papers on M. 
abscessus typing using Diversilab. Some of the articles described problems with 
reproducibility among runs with Diversilab (Zelazny et al. 2009; Thomson et al. 
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2013), where the others showed good reproducibility with this method and were 
able to demonstrate distinct clustering among the isolates (Harris et al. 2012; Cheng 
et al. 2013; Jamal et al. 2014; Mougari et al. 2014). Considering the contradictions 
between the publications, this typing method may need some modifications or 
changes by the company to improve its robustness and reliability. 
 
High-resolution melt analysis (HRM) has been used only in recent years for 
identification, mutation gene analysis and strain typing of Mycobacteria. To date, 
there are five papers published using HRM as a rapid diagnostic tool to screen for 
drug resistance in multi-drug resistant TB. (Ong et al. 2010; Ramirez et al. 2010; 
Chen et al. 2011; Lee et al. 2012; Pholwat et al. 2014). There is one paper detecting 
drug resistance in M. leprae using the same technique as used in detecting TB drug 
resistance (Li et al. 2012). They demonstrated that their technique was able to 
screen rapidly for mutations in gene-specific regions they targeted. 
 
There are two papers published utilising HRM for NTM typing. Castellanos et al. 
(2010) used HRM to rapidly identify M. avium subspecies paratuberculosis types and 
compare to previous data from another method (Castellanos et al. 2010). From the 
results, this method could determine the three prevalent types of this species 
rapidly and accurately. Won et al. (2010) used HRM coupled with a broad-based 
PCR to rapidly identify NTM in positive blood culture bottles (Won et al. 2010). 
Results showed a 100% concordance with previously validated methods used for 
initial identification with 46/52 isolates identified. 
 
Overall from the literature, there is little documented evidence of the application of 
these newer techniques for strain typing M. kansasii isolates. 
 
 
 
2.3.3 Current known genotypes of M. kansasii 
 
From DNA-based studies, the literature suggests that there are between five to 
seven strain types of M. kansasii amongst human and environmental isolations. 
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Strain type I is the one most commonly isolated world-wide and known to cause 
disease in humans (Ross et al. 1992; Marras et al. 2002). Picardeau, et al. (1997) 
was the first to confirm that there are five strain types. Alcaide, et al. (1997) was 
able to reproduce and confirm Picardeau’s study using the same methods with 
additional techniques. Just as Alcaide and co-workers replicated the results, Zhang, 
et al. also attained the same conclusions. Richter, et al. identified a new stain type 
calling it number six (VI) (Richter et al. 1999). They used similar techniques to 
Picardeau, et al. (1997) but included  additional sequencing to differentiate the 
strain types. Iinuma, et al. (1997) performed large-restriction-fragment analysis to 
produce results showing greater diversity among strains (sub-types) but were 
unable to group into the accepted strain types. Taillard, et al. (2003) established a 
seventh strain type by similar methods used by Picardeau, et al. (1997). To date, 
there isn’t any further literature to prove or disprove the existence of a seventh 
strain type. 
 
 
2.4 Summary and Implications 
 
Table 3 below is a summary of the literature describing the genotyping methods 
and their advantages as well as disadvantages. Briefly, most of the typing systems 
provide good discrimination overall, however, disadvantages are the requirement of 
specialised equipment and length of time required to perform the tests. 
 
TABLE 3: SUMMARY OF PUBLISHED GENOTYPING METHODS USED TO DIFFERENTIATE M. KANSASII STRAINS. 
Method Advantages Disadvantages Paper 
Phage Typing Need only 10 single 
colonies to work 
Expensive 
Time consuming Strain
  
discrimination was  
not accurate. 
Engel, 1975 
RFLP with MPTR 
probe & IS1652 
probe; Southern blot 
analysis 
PFGE; AFLP analysis 
PRA; Gen-probe 
Many typing 
techniques used and 
5 strains are 
characterised 
S me of these 
methods   could   only 
identify 2/5 strains 
Time consuming 
Specialised  expensive 
equipment is needed 
Picardeau, 1997 
hsp65 PCR-RFLP 
gyrA intein digest 
Gen-probe; 16-23S ITS 
PFGE on type I only 
Good discrimination 
seen with hsp65 & 
PFGE 
Time consuming 
Expensive 
Alcaide, 1997 
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LRF analysis Good  discrimination 
between strains 
Reproducible 
Time consuming 
Expensive analytical 
software is required 
Iinuma, 1997 
16S-23S rRNA spacer 
region 
REA 
Discovered     a     6th 
strain type. This new 
technique helped 
separate out where 
previous methods 
could not 
Time consuming Roth, 2000 
PRA-hsp65 Good discrimination 
Seventh type 
described 
No analysis shown 
Time consuming 
Taillard, 2003 
AFLP of type I only Simplistic technique 
using fewer reagents 
Good discrimination 
seen amongst type I 
Expensive software 
for analysis is required 
Gaafer, 2003 
PRA-hsp65 
PFGE 
Reproducible results 
generated. 
Confirmed previous 
work (Alcaide & 
Picardeau) 
Time consuming 
Expensive software 
needed   for   accurate 
analysis 
Zhang, 2004 
AccuProbe (Hologic) 
Assay 
PCR-RFLP of hsp65 
Good identification 
before typing 
No visual analysis 
shown. AccuProbe can 
miss  some  strains  of 
M. kansasii, maybe 
hence only finding 2 
strain types 
Santin, 2004 
PRA-hsp65 Results visualised 
well in table and gel 
format 
Initial phenotypic 
methods used to 
identify M. kansasii 
found other species 
when strain typing. 
May have missed 
other strains 
Chimara, 2004 
Unknown   (paper   in 
Spanish) 
Insufficient   material 
to determine 
Insufficient material to 
determine 
Leal Arranz, 2005 
PRA-hsp65 Insufficient material 
to determine from 
the abstract alone 
Insufficient material to 
determine from the 
abstract alone 
Jimenez-Pejares, 
2005 
PFGE Insufficient material 
to determine from 
the abstract alone 
Insufficient material to 
determine from the 
abstract alone 
Mimura 2005 
PRA-hsp65 Typed as per Telenti 
and found 3 strain 
types 
No analysis was 
shown. More of an 
emphasis on antibiotic 
testing than strain 
typing 
da Silva Telles, 
2005 
PCR-PRA-hsp65 
ITS with 16S-23S 
rRNA sequencing 
PFGE 
Insufficient material 
to determine from 
the abstract alone 
Insufficient material to 
determine from the 
abstract alone 
Yoshida, 2007 
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RFLP  with  MPTR  & 
IS1652 probes 
   
PFGE Displayed all  data 
and analysis well 
Results  correlated 
with the study 
conducted   in   Brazil 
(da Silva Telles 2005) 
Observed 9 different 
patterns but didn’t 
state if they are the 
common strain 
“types” 
Wu, 2009 
A review article 
which didn’t 
stipulate what 
molecular testing 
was performed 
Insufficient material 
to determine from 
the abstract alone 
Insufficient material to 
determine from the 
abstract alone 
Yoshida, 2011 
LiPA assay 
Identification first 
PRA-hsp65 capillary 
electrophoresis for 
typing 
Accurate 
identification was 
done first 
Used tap water 
samples  along  with 
human  and  an 
animal isolate 
Showed  it  was 
reproducible  and 
accurate 
No visual analysis 
shown for M. kansasii. 
Expensive equipment 
is required as well as 
highly trained staff 
Sadjuda, 2012 
 
2.5 Summary 
 
From these previously published methods, it is clear that a more rapid, accurate and 
cost effective method is required for M. kansasii strain typing. From this the 
following hypothesis was conceived: 
 
 
Newly developed DNA-based genotyping methods are able to characterise and 
differentiate clinically and environmentally sourced strains of M. kansasii. 
 
 
With this hypothesis in mind, access to the latest equipment enables the 
development of more robust and accurate genotyping methods. This can then 
provide a better understanding of the population structure of clinical and 
environmental M. kansasii. This will also provide a basis for establishing a link 
between environmental M. kansasii and human disease. 
21 
Molecular analysis of Mycobacterium kansasii from human and potable water specimens 21 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Molecular analysis of Mycobacterium kansasii from human and potable water specimens 23 
 
 
 
CHAPTER 3: METHODS AND MATERIALS 
 
3.1 Participants and Isolates 
 
Isolates were collected over a period of five years from 2005 to 2010. This time 
interval was selected as a previous study has been conducted on isolates prior to 
2005 at the Queensland Mycobacterium Reference Laboratory. These years were 
also selected to coincide with the Brisbane Water isolates collected from potable 
water around Brisbane and from patient houses (2006-2010). The water isolates 
were investigated by Dr Rachel Thomson as part of her PhD project entitled: 
Characteristics of Nontuberculous Mycobacteria from a Municipal Water 
Distribution System and Their Relevance to Human Infections (completed 2013). 
171 isolates were originally selected for this study (85 patient isolates and 86 water 
isolates) but after further investigation of the isolates, some had to be excluded as 
they were either not M. kansasii or not viable. The final number of isolates used in 
the current study was 139 plus M. kansasii ATCC 12478 control strain. 
 
 
 
FIGURE 4 ABOVE DEMONSTRATES WHERE THE PATIENT RESIDED AT THE TIME OF SPECIMEN COLLECTION AND 
SUBSEQUENT ISOLATION OF M. KANSASII. THE X-AXIS IS THE REGIONS IN QUEENSLAND THAT WAS REPRESENTED IN 
THIS STUDY AND THE Y-AXIS DEMONSTRATES THE NUMBER OF PATIENTS. 
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3.2 Methodology 
 
3.2.1 Isolation and cultivation methods 
 
 
Patient isolates were collected and stored at the Queensland Mycobacterium 
Reference Laboratory. Patient isolates were obtained from a range of specimens 
including sputum, broncho-alveolar lavage fluid, bronchial-washings, swabs and 
other fluids. 
 
On receipt of the specimens at QMRL, the specimens were decontaminated with 4% 
sodium hydroxide for 30 minutes and titrated to a pH7 with 1 molar phosphoric acid 
to destroy normal respiratory flora and reduce overgrowth by rapid growing 
bacteria. Specimens were cultured in liquid (BACTEC™ MGIT™ 960 Mycobacterial 
Detection System, BD) and solid (Lowenstein-Jensen agar - BD) media for up to ten 
weeks (Somoskovi et al. 2000). This ten-week window provides sufficient time to 
allow very slow growing NTM time to propagate. When a culture was obtained, 
either in liquid or solid media, smear microscopy was performed by Ziehl-Neelsen 
(Kinyoun 1915) and observed by oil-immersion light microscopy. Solid and liquid 
NTM morphology can differ significantly. It is important to distinguish M. 
tuberculosis isolates from NTM. Figure depicts the different morphologies of M. 
tuberculosis and M. kansasii. 
 
 
   
 
FIGURE 5: SMEAR MICROSCOPY FROM CULTURE, ON THE LEFT IS M. TUBERCULOSIS COMPLEX AND ON THE RIGHT IS M. 
KANSASII; VIEW SEEN AT X100 UNDER OIL-IMMERSION. SCALE FOR THE FIGURES ABOVE: 1 = 1 MICRON. AN ARROW 
HAS BEEN ADDED TO SHOW THE READER WHAT TO LOOK AT SPECIFICALLY. PICTURES WERE TAKEN AND PROVIDED BY THE 
AUTHOR OF THIS DOCUMENT. 
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The cord factor (Julian et al. 2010) is what differentiates M. tuberculosis complex 
from other species. Cord factor can also be seen in some NTM species (Julian et al. 
2010) but not as clearly defined as it is for M. tuberculosis complex. In NTM species 
it is seen as loosely corded Acid Fast Bacilli, not the tight serpentine cording 
associated with M. tuberculosis complex. A rapid test to help discriminate M. 
tuberculosis complex from NTM is the MPT64 Antigen assay. Briefly, it is an 
immunochromatographic identification test that uses a gold labelled antigen which 
detects the protein MPT64 that is unique to M. tuberculosis complex isolates (Ismail 
et al. 2009). 
 
M. kansasii is in the Photochromogen group classified by Runyon (Runyon 1959). 
From Figure , the growth on solid media to the right is typical for M. kansasii; they 
are defined as buff raised colonies on solid media with the development of pigment 
after exposure to light. Before pigmentation is present, the colonies are cream in 
colour, with a very close similarity to M. tuberculosis complex on solid media. 
Pigment colour varies between a bright yellow to a dark orange. Organisms are 
stored in an enrichment broth (Dubos broth - BD) and frozen at -800C in aliquots 
until required. 
 
FIGURE 6: MACROSCOPIC VIEW OF M. KANSASII IN LIQUID CULTURE ON THE LEFT (MGIT™) AND SOLID MEDIA ON THE 
RIGHT (LOWENSTEIN-JENSEN). AN ARROW HAS BEEN ADDED TO SHOW THE READER WHAT TO LOOK AT SPECIFICALLY. 
PICTURES WERE TAKEN AND PROVIDED BY THE AUTHOR OF THIS DOCUMENT. 
 
 
3.2.2 Identification Techniques 
 
Identification of NTM at QMRL is performed using a variety of molecular methods 
including the commercially available kit GenoType Mycobacterium CM Line Probe 
Assay (Hain  Lifescience  GmbH,  Germany),  16S  rRNA  sequencing  and   hsp65 
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sequencing. Description of the Line Probe assay is briefly as follows: DNA is 
extracted from culture, amplified and detected via a reverse hybridisation and 
alkaline phosphatase reaction on a membrane strip. This assay is robust and time 
effective but can only differentiate between 14 common species of Mycobacteria 
including M. tuberculosis complex. 
 
When a result cannot be determined by the Line Probe method, 16S rRNA and 
hsp65 sequencing is performed. Both genes effectively differentiate between the 
species, but there are some species of Mycobacteria that have identical 16S rRNA 
sequences. For example some strains of M. kansasii have been found to be 
identical to M. gastri. When species have identical 16S rRNA sequences, they can 
be further differentiated using the hsp65 gene. The 16S rRNA species-specific 
primers are: 
 
Forward - BF 5’-AGAGTTGGATCCTGGCTCAG-3’ 
Reverse - R2 5’-CCTACGAGCTCTTTACG-3’ (Abed et al. 1995). 
 
 
For hsp65 the primers are: 
Forward - A11 5’-ACCAACGATGGTGTGTCCAT-3’ 
Reverse - A12 5’-CTTGTCGAACCGCATACCCT-3’ (Devallois et al. 1997). 
 
 
Details for the sequencing protocol performed are located in Appendix D (QMRL 
2014) 
 
Once it has been established that M. kansasii has been identified, these isolates are 
subsequently used for the genotyping assays. 
 
 
3.2.3 DNA Extraction 
 
Of the three strain typing methods described here, DiversiLab is the only method 
that requires a very high purity and concentration of DNA. The only kit that has 
been validated for use with the DiversiLab system is the UltraClean® Microbial DNA 
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extraction kit (MoBio, USA). The kit contains all reagents and tubes required to 
complete the protocol. The following modifications were made to the 
manufacturer’s instructions as there were problems with acquiring a high enough 
concentration of DNA, the modifications made to the protocol are as follows: 
 Collect 10µL loop of culture from solid growth. 
 Add 50µL of solution MD1 and incubate at 950C for 20 minutes. 
 Vortex – maximum speed (12,000g) for 30 minutes. 
 
 
Further explanations of the modifications made to the extraction method are found 
in Chapter 4.2 on page 36. 
 
 
3.2.4 Internally Transcribed Spacer Region with Restriction Enzyme Analysis (ITS- 
REA) 
 
The Internally Transcribed Spacer (ITS) region is a section of non-functional RNA 
located amongst structural ribosomal RNAs (rRNA) on a common precursor 
transcript (Barry et al. 1991; Gurtler et al. 1996). Genes encoding rRNA and spacers 
transpire in tandem repeats that are thousands of duplicates in length, each 
separated by regions of non-transcribed DNA. Sequence evaluation of the  ITS 
region is commonly used because it is easy to amplify (this is due to the large copy 
of rRNA genes) and also has a high level of dissimilarity, even amid closely related 
species (Ben Amar et al. 2012). This is clarified by the comparatively low 
evolutionary pressure acting on a non-functional sequence. 
 
Restriction Enzyme Analysis (REA) is where an enzyme is used to cut DNA at specific 
recognised nucleotide sequence known as a restriction site (Roberts et al. 1976). 
Restriction enzymes are commonly classified into three types (type I, II & III) (Kessler 
et al. 1990). The type used determines whether they cut their DNA substrate at the 
recognition site or if the recognition and cleavage sites are separated from one 
another (Roberts et al. 1976). These enzymes are found in bacteria and probably 
evolved to provide a defence mechanism against invading viruses (Kruger et al. 
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1983). There are over 3000 restriction enzymes that have been studied in detail, 
and more than 600 are available commercially (Roberts et al. 2007). 
 
The method used in this study was described by Roth et al. (Roth et al. 2000) and 
adapted for In-House use by QMRL Supervising Scientist Jim Psaltis (Psaltis 2005). A 
brief description of the method is as follows: 
 
Mastermix was prepared using the following – 
 
 
TABLE 4: PREPARATION OF THE PCR REACTION FOR ITS-REA 
 For 1x Reaction 
PCR Buffer 10x + MgCl2 (Qiagen, Netherlands) 8.0µL 
dNTP’s diluted 1:10 (GE Healthcare, UK) 4.0µL 
SP1 forward Primer (10uM concentration – Sigma 
Aldrich, USA) 5’ACC TCC TTT CTA AGG AGC ACC 
 
0.5µL 
SP2 reverse Primer (10uM concentration – Sigma 
Aldrich, USA) 5’GAT GCT CGC AAC CAC TAT CCA 
 
0.5µL 
0.1% Triton 1.0µL 
HotStar TAQ Polymerase (Qiagen, Netherlands) 0.5µL 
Rnase & Dnase Free Water 30.5µL 
DNA Template 5.0µL 
Total Volume 50.0µL 
 
The product was amplified using the following cycling conditions: 
 
TABLE 5: ITS-REA PCR THERMAL CYCLING CONDITIONS 
Initial Denaturation 940C – 5 minutes 1 cycle 
Denaturation 940C – 1 minute  
45 cycles Annealing 590C – 1 minute 
Extension 720C – 1 minute 
Final Extension 720C – 1 minutes 1 cycle 
Hold 40C - Hold  
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The PCR amplicons were visualised by gel electrophoresis using 2% 
agarose gel run at 100 Voltage constant for 60 minutes. The product 
size should be between 205-320bp. 
 
REA – Three enzymes were used, namely, HaeIII (Haemophilus 
aegyptius), Cfo1 (Clostridium formicoaceticum) and Dde1 (Desulfovibrio 
desulfuricans). Each enzyme is prepared using the following 
Mastermix. 
 
TABLE 6: PREPARATION OF THE ENZYME DIGEST FOR EACH OF THE THREE ENZYMES 
 For 1x Reaction 
For HaeIII  
Buffer x10 (sure/cut Buffer M) 2.5µL 
RE HaeIII (10u/uL) 0.2µL 
Injection water 13.3µL 
For Cfo1  
Buffer x10 (sure/cut Buffer L) 2.5µL 
RE Cfo1 (10u/uL) 0.2µL 
Injection water 13.3µL 
For Dde1  
Buffer x10 (sure/cut Buffer H) 2.5µL 
RE Dde1 (10u/uL) 0.2µL 
Injection water 13.3µL 
  
Template (from ITS PCR) 10µL 
(for each enzyme) 
Total volume 25µL 
(for each enzyme) 
 
Each enzyme digest reaction was incubated at 370C for 90 minutes. 
Thereafter, the digested products were visualised on a 3% agarose gel, 
including a low mass ladder. 
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3.2.5 M. kansasii genotyping using DiversiLab 
 
DiversiLab™ (bioMerieux, USA) uses the patent technology of rep-PCR. Repetitive 
elements are interspersed with repetitive sequences and these sequences are 
characterised as relatively short (usually <500bp), non-coding, dispersed elements 
in bacterial genomes. The number and spacing of repetitive elements varies from 
genome to genome. The primers target the repeat region and amplify sequences 
between the repeats. Multiple fragments of varying lengths are generated and the 
amplified fragments are separated by size, producing a unique molecular 
fingerprint. Combining the primers from multiple repetitive elements, results in a 
higher level of discrimination between species and strains; hence the fingerprint for 
analysis and comparison. From the fingerprints generated, further analysis can be 
conducted and produced automatically by the software once the particular 
fingerprints are selected for investigation. The software constructs dendrograms 
with the fingerprints aligned in order of relatedness using multiple analysis tools. 
Other representations of the data produced by the DiversiLab software include 
similarity matrix, graph overlay and scatter plot. 
 
M. kansasii isolates were genotyped using the DiversiLab method as per the 
protocol, which is briefly outlined below: 
 
Using the DNA previously prepared, a primary amplification of the repetitive 
elements using a Mastermix is created. The volumes have been altered and 
are outlined below: 
TABLE 7: MASTER MIX VOLUMES FOR DIVERSILAB 
 For 1x Reaction 
MasterMix1 (MM1) – from DiversiLab kit 14.4µL 
10x PCR Buffer (Applied Biosystems, USA) 2.0µL 
Primer Mix – from DiversiLab kit 1.6µL 
AmpliTaq DNA Polymerase (Applied Biosystems, USA) 0.4µL 
DNA Template 1.6µL 
Total Volume 20.0µL 
31 
Molecular analysis of Mycobacterium kansasii from human and potable water specimens 31 
 
 
 
 
 
 
PCR performed using the following thermal cycling conditions: 
 
TABLE 8: DIVERSILAB PCR THERMAL CYCLING CONDITIONS 
Initial Denaturation 950C – 5 minutes 1 cycle 
Denaturation 950C – 30 seconds  
35 cycles Annealing 660C – 45 seconds 
Extension 720C – 60 seconds 
Final Extension 720C – 5 minutes 1 cycle 
Hold 40C – hold  
 
The lab chip was then loaded and ran as per the manufacturer’s instructions. 
 
 
Fingerprint analysis was performed on these results to create the final 
dendrogram and strain pattern. Before a report can be generated, Quality 
Control (QC) was performed on each sample using the DiversiLab software. 
The software QC feature flags obviously abnormal curves and allows 
exclusion of these samples. Reports were generated directly after QC has 
been checked. The software also identifies marker peaks and normalised 
data automatically. After acknowledging the results for each run, a printable 
report was generated and the dendrogram with scatter post were created. 
An example is shown below of what is generated by the software. 
 
 
 
 
 
FIGURE 7: DIVERSILAB FINGERPRINT GENERATED BY SOFTWARE. 
 
 
 
 
3.2.6 Genotyping of M. kansasii using High Resolution Melt Analysis (HRM) 
 
HRM is an extension of DNA dissociation analyses (Qiagen 2013). It is used to 
characterise DNA samples according to their dissociation behaviours as they switch 
from double stranded DNA (dsDNA) to single stranded DNA (ssDNA) with increasing 
temperatures (CorbettLifeScience 2006).  Depending on the G-C content, different 
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melt curves will be generated for each isolate.  Using the Rotorgene 6000 Real Time 
PCR instrument (Qiagen, Australia), fluorescent signals with much greater optical 
and thermal precision are generated compared to previous methods 
(CorbettLifeScience 2006). Prior to performing a HRM analysis, a target sequence 
must first be purified to a high copy number (CorbettLifeScience 2006).  This is done 
by a PCR procedure in the presence of a dsDNA intercalating fluorescent dye 
(CorbettLifeScience 2006). The dye (in this case SYBRGreen) does not interact with 
ssDNA but intercalates with dsDNA and fluoresces brightly in this state (Wittwer et 
al. 2003;  CorbettLifeScience 2006). Initially, the fluorescence is high in a melt 
analysis because the sample starts as dsDNA, but fluorescence diminishes as the 
temperature is raised and DNA dissociates into single strands (CorbettLifeScience 
2006). The observed melt is characteristic for every sample, as seen in Figure . 
 
FIGURE 8: HRM MELTING CURVE, IMAGE SOURCE: WWW.SCIENCEDIRECT.COM. THE MELTING CURVE SHOWS THE 
TEMPERATURES OF WHERE THE DNA DISSOCIATES FROM EACH STRAND. 
 
 
 
HRM was performed and outlined briefly: 
Prepare Mastermix as outlined in the table below – 
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TABLE 9: PREPARATION OF HRM REACTIONS 
 For 1x Reaction 
Type-IT® HRM PCR Kit (Qiagen, Netherlands) 7.5µL 
Rnase/Dnase free water 10.0µL 
Forward Primer – 16S rRNA* (10µM) 0.25µL 
Reverse Primer – 16S rRNA* (10µM) 0.25µL 
DNA Template 2.0µL 
Total Volume 20.0µL 
* 16S rRNA primer sequences are listed in section 3.2.2 above. 
Mastermix and DNA template was dispensed into specific Rotorgene 
compatible tubes. All samples were run in duplicate and included in every 
run is a positive control, a no-template control and a water control. 
 
Real-time PCR was performed initially followed by HRM using the following 
thermal cycling conditions: 
 
TABLE 10: HRM PCR THERMAL CYCLING CONDITIONS 
Initial Denaturation 950C – 10 minutes 1 cycle 
Denaturation 950C – 10 seconds  
40 cycles Annealing 520C – 15 seconds 
Extension 720C – 30 seconds 
Hold 720C – 5 minutes 1 cycle 
HRM Melt from 720C to 950C rising by 0.050C at each step 
 
Analysis of results is described further below. 
Validation of the HRM curves was done by performing Clustal W analysis of 
all 16S rRNA sequences for all isolates. A phylogenic tree was drawn to 
visualise the isolate  clusters  using  the  software  Geneious  version  6.1.4. 
 
The following parameters were used for drawing the tree: 
o Perform Clustal W analysis and import the file 
o Select Mr Bayes, then Substitution Model JC69 
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o Rate Variation is Gamma and all other settings are left on Default. 
o When  interpreting,  a  Value  of  1  means  completely  identical  the 
Reference Strain ATCC12478. 
 
 
 
3.3 Summary of experimental plan 
 
From the results generated from all methods for both clinical and water isolates, a 
comparison was produced to determine strain types of each isolate. ITS-REA was 
performed and analysed at first, as a known profile was produced to determine its 
strain type. To define the strain type, the enzyme digest key defined by Roth, et al. 
which displays the profiles for each M. kansasii type, was used (Roth et al. 2000). 
 
For DiversiLab, once the QC was performed and completed for each isolate and 
each isolate has sufficient peaks for an accurate fingerprint, a dendrogram tree was 
drawn. This was done using the DiversiLab software version 3.4.38 with Pearson 
correlation co-efficient and unweighted pair group method with arithmetic means 
(UPGMA). This was used to compare the isolates and establish clonal relationships. 
DiversiLab similarity cut off values are determined as >97% - indistinguishable, >95% 
- similar and <95% - different. 
 
 
HRM analysis was used for the first time to strain type M. kansasii. Not only was 
HRM performed, but a full Clustal W analysis looking specifically at the 16S 
sequence of all the isolates was also undertaken. From these sequences, a 
phylogenic tree was drawn using the software program Geneious version 6.1.4. 
 
3.4 Ethics 
 
This project had ethical approval under the following units: The Queensland 
University of Technology Research Ethics unit (Approval No. 0900000085) and the 
Human Research Ethics Committee of the Prince Charles Hospital (EC 2617). 
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CHAPTER 4: RESULTS 
 
4.1 Resuscitation of isolates 
 
Selected isolates were removed from -800C permanent storage collection and 
thawed to room temperature. One Lowenstein-Jensen slope was inoculated with 
250µL of Dubos broth (BD, USA) from the storage Cryo tube. Slopes were 
subsequently incubated at 360C for up to 6 weeks to allow resuscitation of 
isolates. Any isolates that were overgrown with non-acid fast organisms were 
decontaminated and inoculated into fresh Dubos broth and Lowenstein-Jensen 
slopes. The recovery rate of patient and environmental isolates was greater than 
95%. Any isolates that didn’t typically resemble M. kansasii were subjected to 
DNA extraction and were further identified using either 16S rRNA or hsp65 
sequencing. Isolates identified as NTM other than M. kansasii were excluded from 
the study. 
 
 
4.2 DNA Extraction 
 
As previously stated, the only kit that we could use for DNA extraction that was 
validated, specifically for the DiversiLab assay, was the UltraClean® Microbial DNA 
extraction kit (MoBio, USA). In order to obtain high quality as well as a sufficient 
volume of DNA to perform the genotyping experiments in this study, modifications 
to the protocol were carried out. Specific modifications included: 
1. In step number 4, the incubation temperature and time increased from 
650C to 950C and from 10 minutes to 20 minutes respectively to allow for 
cell wall lysis to release the DNA contained. 
2. In step number 5, the vortex time was increased from 10 minutes to 40 
minutes to aid in cell wall lysis 
3. In step number 16, the elution volume of MD5 solution was increased 
from 35µL to 50µL, to ensure sufficient amount of DNA for all three 
methods used in this study. 
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According to the manufactures instruction for DiversiLab, for a successful 
fingerprint to be generated a concentration of DNA was required to be 25- 
50ng/uL. Below is a chart to demonstrate the distribution isolate 
concentration ranges. The X-Axis demonstrates the DNA concentration 
obtained and the Y-Axis shows the number of isolates for each category of 
DNA concentration 
 
 
 
FIGURE 9: DNA CONCENTRATIONS ACQUIRED FROM DNA EXTRACTIONS USING THE MOBIO KIT (NG/UL) 
Full results for each patient can be found in the Appendix. 
 
 
 
4.3 DiversiLab 
 
The PCR, preparation of DiversiLab chips and fingerprint analysis was performed as 
per the protocol supplied by bioMerieux, USA. Previous publications have 
described inconsistencies in the reproducibility of the DiversiLab method, and 
initially, this was also found in this study. Frequently an error of “low intensity” 
was received as a result of insufficient DNA (approximately 40% of extractions), in 
the samples. Modifications to DNA extraction outlined above appeared to help 
resolve these issues by decreasing the low intensity result to less than 
approximately 5%. 
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The DiversiLab v3.4.38 software was used to create a dendrogram of all the 
isolates (Appendix B). As per the protocol, analysis was performed using the 
Pearson correlation co-efficient and Unweighted Pair Group Method with 
Arithmetic Means (UPGMA) to compare isolates and determine clonal 
relationships. Any isolates that were 97% similarity were considered to be 
indistinguishable. Isolates that showed 95% similarity were considered similar and 
isolates with ≤95% were considered to be unrelated. 
TABLE 11: NUMBER OF ISOLATES FALLING INTO EACH CATEGORY FOR RELATEDNESS WITH DIVERSILAB 
 Indistinguishable Similar Unrelated **Strain Clusters 
Patient 14 36 24** 19 
Environmental 17 12 32** 26 
** Strain Clusters – defined as the amount of strain types that are unrelated at a 
≤95% correlation. As a summary, there are 19 strain variants amongst the 24 
Patient isolates and there are 26 strain clusters amongst the 32 Environmental 
isolates. 
 
 
4.4 High Resolution Melt Analysis (HRM) 
 
HRM was performed on all isolates used in this study. The HRM assay was found 
to be highly sensitive, as only 5-10ng/µL of DNA was required compared to 25- 
50ng/µL of DNA required for the DiversiLab method. To determine whether the 
strain type of each isolate, a criteria of either “same” or “different” was used as 
previously described by (Price et al. 2007) and (Stephens et al. 2008). A +5 
Fluorescent Units (U) or a -5 U was used as the comparator in determining 
whether the strain was the same or different. When an isolate is greater than 5 U 
in the difference graph, it is considered to be different. If the isolate is less than 5 
U, the isolate is deemed to be the same as the control used to compare. For this 
study, the ATCC 12478 M. kansasii strain was used as the comparator. Below are 
some examples of these normalised and difference graphs. In Appendix C, the full 
HRM data is displayed. 
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FIGURE 10: NORMALISED HRM CURVES OBTAINED FROM THE ROTORGENE 6000 SOFTWARE OF M. KANSASII PATIENT 
ISOLATES. Y – AXIS IS THE NORMALISED FLUORESCENCE AND X – AXIS IS THE MELTING TEMPERATURE IN DEGREES 
CELSIUS. 
 
 
 
FIGURE 11: NORMALISED HRM CURVES OF WATER M. KANSASII ISOLATES. Y – AXIS IS THE NORMALISED 
FLUORESCENCE AND X – AXIS IS THE MELTING TEMPERATURE IN DEGREES CELSIUS. 
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FIGURE 12: A DIFFERENCE CURVE FOR A PATIENT M. KANSASII ISOLATE WHICH IS ILLUSTRATING THE “SAME” PROFILE AS 
THE CONTROL M. KANSASII ATCC 12478 STRAIN. Y – AXIS IS THE NORMALISED FLUORESCENCE MINUS THE REFERENCE 
STRAIN AND X – AXIS IS THE MELT TEMPERATURE IN DEGREES CELSIUS WHERE THE STRAIN DEVIATES FROM THE 
REFERENCE STRAIN. 
 
 
 
FIGURE 13: DIFFERENCE CURVE FOR A WATER M. KANSASII ISOLATE WHICH IS DEMONSTRATING THAT THE ISOLATE IS A 
“DIFFERENT” PROFILE AND NOT THE SAME STRAIN AS THE CONTROL. Y – AXIS IS THE NORMALISED FLUORESCENCE 
MINUS THE REFERENCE STRAIN AND X – AXIS IS THE MELT TEMPERATURE IN DEGREES CELSIUS WHERE THE STRAIN 
DEVIATES FROM THE REFERENCE STRAIN. 
 
 
4.5 Validation of HRM results 
 
16S rRNA sequencing was performed on each of the isolates in order to validate 
the separation of the HRM curves. These sequences were aligned using the Clustal 
41 
Molecular analysis of Mycobacterium kansasii from human and potable water specimens 41 
 
 
 
 
W alignment function of the BioEdit software program (version 7.2.5).  A typical 
output from the alignment is shown in Figure below. 
42 
Molecular analysis of Mycobacterium kansasii from human and potable water specimens 42 
 
 
 
 
 
 
FIGURE 14: CLUSTALW ALIGNMENT OF M. KANSASII PATIENT AND WATER ISOLATES. SINGLE NUCLEOTIDE 
POLYMORPHISMS (SNP) WERE OBSERVED FOR STRAINS THAT DEVIATED FROM THE M. KANSASII ATCC 12478 
REFERENCE STRAIN. VISUAL INSPECTION OF THESE SEQUENCES DETERMINED THAT STRAIN TYPES I, IV & V’S COULD BE 
SEPARATED BASED ON EACH CLUSTER’S SNP DIFFERENCES. 
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A phylogenetic tree was created using the Mr Bayes application as input for the 
Geneious version 6.1.4 program. The HRM assay was quick to perform (three hour 
turnaround time per run) on a large set of isolates tested in this study. From the 
data produced, HRM showed good inter-run reproducibility as seen by the melt 
curve temperatures being very close together. The complete set of HRM results 
and associated Phylogenetic tree are listed in Appendix D: HRM Results.  Below is 
a graphical summary of the results for same vs. different as previously described 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 15: GRAPHICAL REPRESENTATION OF SAME VS DIFFERENT NUMBERS OF ISOLATES DETERMINED BY HRM. THIS IS 
SHOWN FOR BOTH PATIENT ISOLATES AND WATER ISOLATES. 
 
 
4.6 ITS-REA 
 
This method was robust and reproducible and it produced clear product 
differentiation on the electrophoresis gel images. As devised by Roth et al. (2000), 
the strain types each had a clear pattern to distinguish particular strain types from 
each other (Roth et al. 2000). Using gel electrophoresis, each isolate was clustered 
into a strain type by this method based on its particular 16S-23S sequence. When 
we use this to compare with the 16S rRNA sequences of M. kansasii, most strains 
only contained one nucleotide change difference. Specifically, this can be 
observed between nucleotides 461-469 of the 16S rRNA region (Table 12 below). 
As it is only a single nucleotide difference, it is not a reliable method for strain 
N
u
m
b
er
 o
f 
is
o
la
te
s 
p
er
 c
at
eg
o
ry
 
44 
Molecular analysis of Mycobacterium kansasii from human and potable water specimens 44 
 
 
 
 
differentiation. The 16S-23S showed better differentiation and hence it is superior 
for subtyping within the M. kansasii species. Figure 16 shows the strain type 
proportion of both the patient isolates and water isolates. 
 
 
The electrophoresis gel pictures images for isolates tested in this study are located 
in Appendix B: ITS-REA Enzyme Digest Gel Pictures. 
 
 
TABLE 12: NUCLEOTIDE CHANGES BETWEEN STRAINS TYPE OF M. KANSASII AS ADAPTED FROM (ROTH ET AL. 2000) 
M. kansasii strain type 16S rRNA sequence profile nucleotide 461-469 region. 
Type I CGG CTT CTC 
Type IV CGG GTT TTC 
Type V CGG GTT TCC 
 
 
 
FIGURE 16: STRAIN TYPE PROPORTION OF PATIENT AND WATER ISOLATES DEMONSTRATED IN A PIE CHART. THE 
PROPORTION BETWEEN BOTH THE PATENT ISOLATES AND THE BRISBANE WATER ISOLATES ARE SURPRISING. THE 
PATIENT STRAIN TYPE DOMINANT IS TYPE I BUT THE WATER STRAIN TYPE DOMINANT IS TYPE V. 
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4.7 M. kansasii genotyping results summary 
 
Results from all three genotyping assays (DiversiLab, HRM and ITS-REA) have been 
presented as a Venn diagram to show each strain type with the three typing 
methods and how well they correlated with each other. A scatterplot of each 
patient and water isolates created by DiversiLab software has also been included as 
another form for visualisation of results. Finally a table representation of  the 
results is also included. 
Venn Diagrams are seen below and they illustrate the relationship between each of 
the assays and demonstrate how many isolates correlate with the other typing 
methods performed. 
 
 
 
 
 
 
Abbreviations: 
 
 ITS-REA: Internally Transcribed Spacer region with Restriction Enzyme Analysis. 
ITS-REA  is  the  assay  that  grouped  the  isolates  used  in  this  study  into  the 
previously identified three main strain types (I, IV & V).   This is why a 100% 
strain type identification using this was standardised. 
 HRM: High Resolution Melt analysis. 
HRM showed relatedness to strain type I only and no strain relationship with 
type IV or V. This was due to the control strain used in this project (only one 
available) being closely related to strain type I. 
 Numbers in the Boxes: demonstrate how many isolates match to the previously 
assigned strain types using ITS-REA as the basis for the analysis. 
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FIGURE 17: VENN DIAGRAM OF THE NUMBER OF M. KANSASII PATIENT AND WATER ISOLATES COMBINED FOR ITS- 
REA STRAIN TYPE I. SEE PAGE 46 FOR THE ABBREVIATIONS AND DEFINITIONS. 
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FIGURE 18: VENN DIAGRAM OF THE NUMBER OF M. KANSASII PATIENT AND WATER ISOLATES COMBINED FOR ITS- 
REA STRAIN TYPE IV. SEE PAGE 46 FOR THE ABBREVIATIONS AND DEFINITIONS. 
48 
Molecular analysis of Mycobacterium kansasii from human and potable water specimens 48 
 
 
2 
2 0 
2 0 0 
 
 
 
 
ITS-REA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DiversiLab 
 
HRM 
 
 
 
 
 
 
 
 
 
 
FIGURE 19: VENN DIAGRAM OF THE NUMBER OF M. KANSASII PATIENT AND WATER ISOLATES COMBINED FOR ITS- 
REA STRAIN TYPE V. SEE PAGE 46 FOR THE ABBREVIATIONS AND DEFINITIONS. 
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FIGURE 20: SCATTERPLOT OF M. KANSASII WATER ISOLATES. THE STRAIN TYPES DETERMINED BY THE ITS-REA ARE 
COLOUR CODED (I, IV & V) AND ISOLATES WERE GROUPED BY THEIR INDIVIDUAL FINGERPRINT GENERATED FROM 
DIVERSILAB SOFTWARE. 
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FIGURE 21: SCATTERPLOT OF M. KANSASII PATIENT ISOLATES. THE STRAIN TYPES DETERMINED BY THE ITS-REA ARE 
COLOUR CODED (I, IV & V) AND ISOLATES WERE GROUPED BY THEIR INDIVIDUAL FINGERPRINT GENERATED FROM 
DIVERSILAB SOFTWARE. 
 
 
 
TABLE 13: COMPARISON OF THE THREE M. KANSASII GENOTYPING METHODS EXAMINED 
51 
Molecular analysis of Mycobacterium kansasii from human and potable water specimens 51 
 
 
 
 
 
 
 
As a summary of the figures and tables provided to show the visual analysis, Figure 
16-18 are Venn diagrams to show how each strain type of M. kansasii matches up 
per strain typing method. Figure 19 and 20 are Scatterplots generated by 
DiversiLab Software. It is an excellent visual tool to show how much diversity there 
is between every isolate both Patient and Environmental. Table 13 is a summary 
handy for a Diagnostic Laboratory as it demonstrates Turn-Around-Time for the 
assay as well as the Cost, Typeability and Sensitivity. 
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CHAPTER 5: DISCUSSION & CONCLUSIONS 
 
5.1 Previously used typing methods 
 
Strain typing has progressed over time as highly-advanced technologies have 
become available to better differentiate and subtype species of Mycobacteria. The 
first typing method described used bacterial phages to strain-type Mycobacteria 
(Engel 1975). Currently, DNA-based assays are considered the gold standard as the 
demand for more rapid and cost effective methods increases. 
 
 
From the previously discussed methods found in the literature for M. kansasii, each 
assay had positive and negative attributes with regards to reproducibility, specificity 
and sensitivity. Engel’s technique required specialised equipment and many weeks 
to perform the assay (Engel 1975). In addition, phage typing doesn’t provide the 
level of specificity required to accurately and robustly type NTM isolates. Picardeau 
et al. (1997) were the first to investigate a variety of different DNA-based assays for 
typing bacterial isolates. RFLP with the MPTR probe, PFGE, AFLP & PRA 
demonstrated excellent reproducibility and typeability across all strain types. The 
IS1652 probe could only detect types II & III but could discriminate sub-groups of 
type II better than any other assay and AccuProbe couldn’t detect types II, III or IV. 
Each of the assessed assays had positive and negative aspects with regards to 
specificity and sensitivity and the requirement of specific equipment for some of 
these methods. Overall, Picardeau et al. demonstrated that the previously 
established five strain types of M. kansasii were identified by the assays previously 
discussed. Some of the methods revealed polymorphisms, which then allowed for 
further strain differentiation. 
 
 
Alcaide et al. (1997) used a specific housekeeping gene hsp65 with restriction 
fragment length polymorphism PCR, followed by enzyme digest and visualisation of 
products on an agarose gel. They also evaluated other techniques similar to 
Picardeau (1997) and obtained similar results overall. Again, most of these 
techniques could not be used for this study due to the lack of specific expensive 
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equipment required to perform the assays such as PFGE tanks with current/voltage 
controlling apparatus and gel quantification analysis software and equipment. 
Similarly, methods described by Iinuma et al. (1997) who used large restriction 
fragment length polymorphisms, digested with VspI and visualised on PFGE could 
not be applied in this study due to the lack of specialised equipment. They 
demonstrated varieties of different subtypes within known types M. kansasii strains 
as well successfully replicating their results. Some subtypes were also compared 
using 16S rRNA sequencing and it was noted that  all isolates tested from one 
subtype classification had identical sequences. A disadvantage to this assay is the 
length of time required to obtain results. It takes many days to perform this test 
from start to finish as a high quality DNA product yield is required initially. 
 
 
Other groups that used the same techniques as described  by the Picardeau & 
Iinuma researchers were: Gaafar et al. (2003), Taillard et al. (2003) and Zhang et al. 
(2004). There were also some retrospective studies performed by Santin et al. 
(2004) and Chimara et al. (2004), where the focus of these studies were to report 
on the demographics of infection with regards to HIV status of the patients whose 
isolates were used in the study. From the results published, they concurred to a 
degree with our results. They each described strain type I as the most dominant 
type in each study, which matched our findings from this research. Most described 
type II and III isolates, however these were not found amongst the Queensland 
isolates studied. We could suggest that maybe these particular strains are 
geographic specific as they’ve not been isolated in Queensland before (Psaltis 
2005). 
 
 
The assays discussed above have demonstrated advantages and disadvantages with 
regards to reproducibility, specificity and sensitivity. Apart from not having access 
to the equipment for most of the methods described previously, it was necessary to 
develop and validate more accurate and robust typing methods. These new 
methods are required to provide a greater level of strain discrimination, improve 
Molecular analysis of Mycobacterium kansasii from human and potable water specimens 56 
56 
 
 
 
 
cost effectiveness and ability to attain rapid strain typing results with equipment 
available in a routine diagnostic laboratory. 
 
 
5.2 The main aims produced by this study 
 
There were two main aims in this study which were: 
 
1. To genotype M. kansasii isolates using new and existing genotyping 
methods; and 
2. To compare the strain genotypes of M. kansasii isolates from clinical 
samples to those obtained from Brisbane water and patient home water 
samples. 
In addressing these aims, the following conclusions can be made: 
 
 
 
Aim 1 – 
 
The DiversiLab method was used to produce genotypic fingerprints and 
dendrograms for all isolates tested in this study. There were some issues with the 
reproducibility of the assay, consistent with those previously described (Zelazny et 
al. (2009), Cheng et al. (2013) and Thomson et al. (2013). Using this technique as 
the only diagnostic tool for Mycobacterium sp. is a possibility but could be limited 
due to the reproducibility related to the difficulty in obtaining sufficient DNA 
required. The DiversiLab software program is user-friendly and can provide a wide 
range of analytical tools, such as the fingerprint dendrograms as demonstrated, as 
well as scatterplots and pyramid plots, all at the touch of a button. 
In order to obtain sufficient, high quality DNA for the DiversiLab method, the 
extraction protocol had to be altered significantly. If the manufacturer could 
guarantee a reproducible assay with consistent results and competitive pricing, 
then DiversiLab would be a better alternative to PFGE or other genotyping methods. 
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Initially, the development and application of HRM as a strain typing method was 
difficult to do, as this method is novel for genotyping M. kansasii isolate. Factors in 
determining how to make this assay viable included – looking specifically at the test 
conditions, the primer selection as well as how to perform analysis validation. 
However, the only downfall of the HRM genotyping method  is that it requires 
comparison to known strain types in order to assign unknown strains to a specific 
type. Sequencing analysis of the 16S rRNA regions showed SNPs unique to each 
strain of M. kansasii. The other benefits of this assay are: it is inexpensive 
(approximately 50 cents per test), running time from start to finish is only 3 hours 
and the analysis is quick and easy to perform, as it doesn’t require highly skilled 
staff to operate or analyse the results. This assay certainly has the potential to be 
the new gold standard for Mycobacterium sp. genotyping in the future. 
 
 
The ITS-REA method proved to be most robust and consistent genotyping method 
of the three methods tested in this study. DNA concentration was not a concern as 
results were obtained irrespective of the quantity and quality of the DNA. However, 
a drawback of this method is that it was difficult to analyse the gel electrophoresis 
images for some isolates, and it was difficult to visualise very faint bands generated 
by enzyme restriction. There was no readily available software program to analyse 
the ITS-REA data and hence the results could only be interpreted by visualising the 
restriction enzyme bands on the gel. This can lead to misidentification of the 
numbering of DNA fragment base pairs. However, together with the DiversiLab and 
HRM results, accurate strain types could be assigned by ITS-REA. Another 
disadvantage of the ITS-REA method is that it is time-consuming and not feasible to 
use in a routine diagnostic laboratory, however, the advantage is that it is a robust 
method providing consistent inter-run results. 
 
 
Aim 2 – 
 
The discriminatory power of each assay varied greatly. DiversiLab was the most 
discriminatory, producing intricate dendrograms which showed differing strains in 
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more detail compared to the other genotyping methods. The dendrogram tree gave 
a percentage similarity which made it easy to detect the clonal strains. After final 
analysis, 31 strains were identified by the DiversiLab method, which was more strain 
types than the other methods. HRM has a high discriminatory potential as well, as it 
can determine one SNP difference when compared to a reference strain. If more 
reference strain types were available, it would have been possible to optimise this 
assay for routine genotyping in a diagnostic laboratory. ITS-REA only has the capability 
for determining the six known strain types of M. kansasii, but it also can determine 
other species of mycobacteria (whereas the DiversiLab and HRM can demonstrate 
differences within the six strain types). DiversiLab also has the capacity to determine 
different species by showing outliers in the dendrogram with significant degrees of 
difference. 
 
 
The strain types obtained from this study are consistent with those reported in 
other regions of the world. Strain type I has been shown to be the cause of the 
majority of clinically significant disease in humans. The most commonly observed 
patient isolate strains observed in this study was strain type I and some type IV and V 
strains were also found. However, the water isolates showed a different picture with 
only one type I isolate found and the rest of the isolates were type IV and V. This 
suggests that water is not likely to be a common source of infection for M. kansasii 
in human disease. Other areas of the world have found type II, III and VI and very few 
strain types IV and V in water (Zhang et al. 2004). This may mean that the 
environmental strains could be location specific. 
 
As a summary for comparing the attributes of each genotyping method for both clinical 
and environmental samples, all methods could identify strain type I.  DiversiLab and ITS-
REA could identify strain types IV and V, but HRM identification could not be validated 
for those strains due to the lack of appropriate reference strains for these genotypes.  As 
we have a large enough sample size to use as a validation, it would be the next logical 
step forward for implementation.  Extrapolating from the data, the strain types that were 
identified by ITS-REA to be type IV and V did appear to cluster tightly using HRM analysis. 
Therefore, this study found that each typing method was able to correctly characterise 
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each of the major strains types found globally.    
 
 
5.3 Optimisation of DNA yield from M. kansasii isolates 
 
Of the three assays used for strain typing, only one required a specific extraction kit. The 
DiversiLab assay recommends that only the UltraClean® Microbial DNA extraction 
kit (MoBio, USA) be used. This is due to the high degree of purity required to give 
reliable fingerprint results.  However this proved to be inadequate and modifications 
had to be made to the extraction protocol to achieve a high DNA concentration. 
 
 
Initially, when the manufacturer’s instructions were followed precisely, problems 
were encountered with low DNA yield (i.e. <10ng/µL). It was clear that 
modifications to the method were necessary to increase DNA concentration. After 
discussions with the company’s technical support, the incubation temperature, the 
incubation time and the vortex time were increased. These changes made a significant 
improvement to the DNA yield with increases in concentration from 
<10ng/µL to 50ng/µL. 
 
 
 
5.4 ITS-REA typing of M. kansasii isolates 
 
The method gave a broad level of species discrimination using the 16S-23S spacer 
region, not seen previously with the 16S rRNA region. As Roth discussed, some 
species of Mycobacteria have the same 16S region (Roth et al. 2000). Using the 16S-
23S spacer region provided better discrimination between many Mycobacterium 
species. When restriction enzyme analysis was applied, sub-species of some of these 
Mycobacteria were discovered. Roth et al. (2000) demonstrated that this method had 
a high level of discrimination between subtypes of M. kansasii. Using the algorithm 
published by Roth et al. (2000), isolates could be allocated a strain type with easy 
interpretation. Using the ITS-REA typing method enabled the exclusion of some 
isolates in this study that were not M. kansasii but M. gastri (species that share 
identical 16S rRNA sequences). 
 
 
 
The ITS-REA assay was selected for this study as it has been used successfully in the QMRL 
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laboratory (Psaltis 2005), allowing an analysis of trends in M. kansasii strain types 
overtime; The patient isolate selection in this study was from 2005 - 2010, specifically 
selected in order to correlate this study’s findings to those found by Psaltis’s previous 
study (2005).   From Psaltis’s research, strain types I, IV, V & VI were described for patient 
isolates from 1975-2004. Compared to the results obtained in this study, only strain types I, 
IV & V were found but no type VI. 
 
 
Worldwide, the distribution of previously defined strain types has shown that M. 
kansasii type I is the most dominant (Alcaide et al. 1997; Iinuma et al. 1997), 
however, in this study, only three strain types were found in Queensland. The 
absence of strain types II and or III could be due to the climatic differences and the 
geographical location of Australia. This assay could also be used as an identification 
method to speciate other mycobacteria. In this study, there were a few isolates 
(seven isolates) that didn’t quite fit the typical ITS-REA pattern for M. kansasii; 
however, further identification using the Roth et al. (2000) algorithm found that 
these isolates were in fact not M. kansasii but other Mycobacterium species. 
 
 
5.5 DiversiLab rep-PCR typing of M. kansasii 
 
DiversiLab is a relatively new strain typing method. One of the first publications that 
compared this method to an established typing method, Pulse Field Gel 
Electrophoresis (PFGE) was published in 2005 (Ross et al. 2005). They found that 
DiversiLab had good intra- and inter-run reproducibility, a rapid turnaround time and 
standardised results. 
 
 
This method was selected for use in this study due to the rapid turnaround time for an 
accurate strain typing result. A fingerprint can be achieved in one day instead of several 
days compared to PFGE. 
 
 
DiversiLab has not been applied to M. kansasii previously, however, it has been 
used to genotype other mycobacterial species such as M. tuberculosis and M. avium 
(Cangelosi et al. 2004). 
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While there has been some work published on the utility of DiversiLab as a typing tool, 
the current study has shown that there was difficulty with the reproducibility of the 
method. This may be due to the fact that M. kansasii in particular have a very dry and 
buff colony morphology type, which may be difficult to lyse and hence the DNA yield is low 
and not of sufficient quality. In the QMRL laboratory, other mycobacterial species such as 
the rapidly growing M. abscessus are easier to extract DNA from. These organisms form 
their mycolic acid wall structure rapidly, and hence, it is easier to lyse the cell wall to 
attain a high yield and good quality DNA. The issue of sufficient high quality DNA is a 
limitation of the DiversiLab system, and it is recommended that at least 25-50ng/µL of high 
quality DNA is used. This requirement is required to produce reproducible typing results. 
Even with this in mind, it was still difficult to attain the minimum amount of DNA 
concentration. This is more than likely the main reason for variation between runs in this 
study. 
 
 
Overall, it was difficult to determine whether the results obtained in this study correlate 
with other findings as currently there are no other reports on the application of the 
DiversiLab method to genotype M. kansasii isolates. What can be deduced is that the same 
difficulties experienced by other researchers were also found in this study. Also, it was 
observed that this method is a more accurate way of typing M. kansasii isolates than ITS-
REA. This study found that the DiversiLab method is a rapid and an improved genotyping 
method compared to previous methods, such as PFGE. This is due to fact that the 
DiversiLab method provides a detailed fingerprint. In concordance with the ITS-REA results, 
the fingerprints generated agreed with the ITS-REA strain types, and hence, strain type 
numbers I, IV and V were assessed using the DiversiLab software. In addition, the 
software enables the detection of sub strain-type populations. This allows for further 
differentiation of strains within each of the strain type groups, therefore DiversiLab is a 
better typing tool than ITS-REA. The DiversiLab software can be used to visualise the data to 
show particular clusters and further details about the isolates can be added such as source 
(environmental/clinical; pulmonary vs extrapulmonary, etc.) allowing visual strain 
comparisons.  An advantage of the DiversiLab is the capability of pooling isolates into one 
dendrogram, unlike the ITS-REA  method where the limitation is the gel size, and in most 
cases multiple gels have to be used when genotyping large numbers of isolates. 
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5.6 High Resolution Melt Analysis of M. kansasii isolates 
 
From published literature, HRM hasn’t been used as a typing method for 
Mycobacteria but has been used more as a diagnostic tool to determine whether a 
resistance trait is present. This study is a first where HRM was used as a M. kansasii 
strain typing tool, and hence, further validation was required to determine the 
robustness of the method in a diagnostic setting. The 16S rRNA region was used as the 
target region for typing M. kansasii isolates, and this region is consistently used in the 
routine diagnostic laboratory at QMRL. 
 
 
The specificity of the HRM method used in this study was limited by access to M. 
kansasii type strains. The HRM assay determined whether unknown test isolates were 
the same or different type to the control M. kansasii type strains. None of the water 
isolates matched the control strain. This is expected because the isolates were 
predominantly types IV & V. Of the 61 type I patient isolates tested, only 15 matched 
(24.59%) the M. kansasii type strain. This could be due to the enhanced sensitivity of 
the HRM method compared to ITS-REA, and that type I sub-strains were found in 
this study. This has been shown for other typing methods by (Alcaide et al. 1997; 
Iinuma et al. 1997). When comparing the HRM results with the DiversiLab patterns, 
the same low percentage of type I isolates matching the M. kansasii type strain 
was found. The DiversiLab also demonstrated a degree of difference amongst the 
type I strains. With respect to DiversiLab, the degree of separation seen amongst the 
type I isolates was only a small percentage. HRM was similar with its results as well. 
When comparing the known type I strains with the 
M. kansasii type strain, most isolates were only slightly greater or slightly lesser 
than the 5 U of deviation (just out of set limits). 
 
 
 
This study found that HRM was a robust and sensitive genotyping tool, which was 
quick and could easily be applied in a routine diagnostic laboratory. This method 
requires a single piece of equipment to perform both the PCR and HRM reactions 
(Rotorgene, Qiagen), the reagents required are minimal, the cost is low and results can 
be obtained in one day. 
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The validation results obtained in this study showed that HRM can determine M. 
kansasii strain type I isolates. M. kansasii type I strains are the most dominant 
strains worldwide (Alcaide et al. 1997; Iinuma et al. 1997), and therefore, HRM is 
ideally suited to rapidly screen M. kansasii isolates in the routine diagnostic 
laboratories worldwide, which will assist clinicians to determine appropriate 
treatment for the patient. There are two notable limitations which limit the 
potential of this assay. Firstly, each run performed can only be analysed on a single 
run basis. Unlike the DiversiLab software where multiple runs can be combined to 
give a full profile, the HRM software doesn’t have the capabilities to merge multiple 
runs together. If isolates from different runs need to be compared, the only way 
possible is to re-run the isolates together. Secondly, only one control strain is 
available. For every run performed, multiple controls are a necessity to complete a 
full analysis. 
 
 
5.7 Conclusions 
 
TABLE 14: SUMMARY OF THE METHODS USED - ADVANTAGES AND DISADVANTAGES OF EACH METHOD. 
 Advantages Disadvantages 
ITS-REA Robust 
Gold Standard 
Costly 
Time consuming 
DiversiLab Quick turnaround time 
Good analysis capabilities 
Costly 
High quantity of DNA required 
HRM Quick turnaround time 
Cheap assay 
Can’t analysis large sample numbers 
Can only analyse by using “same vs 
different 
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ITS-REA method used in this study was useful in broadly determining the M. kansasii 
strain diversity in Queensland compared to previous international benchmarks. 
When comparing patient M. kansasii isolates to environmental isolates, all three 
methods proved to be effective genotyping methods. However, each of the 
methods had advantages and disadvantages, but essentially, each of these methods 
could be used routinely in a diagnostic setting. ITS-REA is laborious and takes 
approximately two days to obtain a result, where both the DiversiLab and HRM 
methods can be done in one day from DNA extraction to obtaining results. Both 
DiversiLab and HRM require specialised platforms, which are not available in all 
routine diagnostic laboratories. The greatest advantage offered by the DiversiLab 
genotyping method is that it can provide clinicians with strain type information 
indicative of either colonisation or disease, which will impact on patient treatment. 
A limitation of the ITS-REA method is that it only provides a broad strain type 
number, whereas both DiversiLab and HRM methods are able to sub-type M. 
kansasii isolates within each ITS-REA group, providing enhanced strain 
discrimination. 
 
 
When considering the cost of each of the three methods, ITS-REA costs 
approximately $30 per isolate, DiversiLab is the most expensive at $48 per isolate 
and HRM is the most inexpensive at only 50 cents per isolate. For a diagnostic 
laboratory where budgets are crucial, HRM would be the obvious genotyping 
method to use. Besides the cost factor, the quick turn-around time of DiversiLab 
and HRM to identify strain types is important. As previously stated, differentiating 
between colonisation vs. disease could potentially impact therapy. It is also 
important to differentiate between relapse vs. reinfection for patients who culture 
multiple isolates over time. Using either assay, a strain comparison can be 
determined quickly. Rapid strain differentiation may also be of particular use in the 
setting of an outbreak, where a particular source is suspected. To determine what 
type of infection the patient has, multiple isolates need to be run in parallel. With 
DiversiLab and HRM, this is possible. 
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There were few limitations in this study. With regards to strain typing, the 
limitations included obtaining high DNA yield required for the DiversiLab method. 
Not knowing how much culture was required at the beginning of the DNA extraction 
was challenging.  Due to the high fatty acid bi-lipid layer of mycobacteria, as well as 
M. kansasii being a very dry buff colony morphology type, made it difficult to lyse 
the cells to release the DNA. At the same time, it was also difficult to ensure the 
quality of the DNA was not affected once the cells were lysed. For example, 
shearing of the DNA during the extraction procedure had to be monitored closely 
during the bead-beating step. It is therefore challenging to ensure good quality and 
sufficient DNA was available to use for the genotyping methods. 
 
 
Further limitations included not having additional M. kansasii reference strain types 
available for use. These strains would have ensured the robustness of the HRM 
assay in enabling accurate strain differentiation and strain identification. Without 
access to a comprehensive collection of M. kansasii strain types, it is difficult to 
establish these methods in a routine diagnostic laboratory. 
 
 
This is the first study to compare three different genotyping techniques applied to 
M. kansasii isolates from both clinical and environmental sources. Results from this 
study have enabled the determination of the most timely, robust and cost-effective 
genotyping method for M. kansasii isolates from diverse sources. HRM showed 
potential for a rapid result of same or different, but DiversiLab proved to be a better 
typing method giving better diversity amongst the defined isolates. 
 
 
Overall, ITS-REA was an important assay to perform for this research. Without the 
results, we could not determine or validate the results that we obtained from the 
two other assays. HRM could only determine an isolate to be either “same” or 
“different”. As disappointing the test results were, this test could be fine-tuned and 
developed further to be a rapid assay in a diagnostic setting.  The only limitation 
that  can  be  foreseen  is  having  enough  data  to  create  an  extensive  library  to 
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compare the test to. DiversiLab was by far the most superior assay as the 
discrimination power was superior to the other assays. The software makes it user 
friendly to analyse and compare isolates against other previous isolates. This has 
the potential for clinicians to retrospectively look at isolates from other patients 
and look for the occurrence of outbreaks and possible clusters. 
 
 
As hypothesised in this study, it was possible to differentiate and characterise all M. 
kansasii strains used in this study.  The DiversiLab method was by far the best at 
differentiating strains, with ITS-REA providing a broad strain “baseline” for strain 
typing. HRM could be used if sufficient reference/known strain types are used as 
controls for the assay. 
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CHAPTER 6: FUTURE DIRECTIONS 
 
 
 
From the results generated by this study, we have established recommendations for 
future work: 
 To investigate other environmental sources of infection, for example soil 
and dust. These environmental sources of M. kansasii infections have not 
been determined in Queensland. 
 Following further optimisation of these assays, they could be implemented 
in the routine diagnostic laboratory. Knowledge of M. kansasii strain types 
could possibly assist clinicians in appropriate patient treatment options. 
 Collecting and filtering water from other parts of Queensland, or even 
other parts of Australia should be done to determine the broader 
distribution of environmental M. kansasii strain types. 
 When mapping of the patients’ addresses, it was found that they resided 
in small area clusters (Chou et al. 2014). Further investigation into their 
water sources or even other potential sources of infection is warranted. 
 
 
Future directions of this research could entail the following: 
 
 Performing Whole Genome Sequencing of the M. kansasii isolates would 
enable detailed strain specific and sub-type identification of type I isolates in 
particular, given that these strains are the dominant types found in most 
parts of the world. In addition, other genetic targets could be identified on 
the genome that could enable improved strain typing of M. kansasii 
compared to ITS or 16S rRNA. 
 Acquiring supplementary reference strains to further validate the HRM 
would be useful and could therefore be implemented into a diagnostic 
laboratory. 
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 Further collection and filtering of water samples from the clustal patient 
areas such as Roma and Toowoomba in Queensland could be performed. 
These areas where high levels of M. kansasii isolation from patients have 
occurred warrant further investigation. 
 Virulence factors have not been published previously. With regards to 
strain types of M. kansasii further investigation into whether one strain type 
is more likely to cause disease than other types would be clinically relevant. 
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Appendices 
 
APPENDIX A1: THE GEOGRAPHICAL LOCATION BY SUBURB AND POSTCODE OF PATIENTS’ FROM WHOM M. KANSASII 
WAS ISOLATED FROM 
 
  AUSLAB#   Patient Name   Patient Location   Postcode   
395755535 PaOk Brisbane City 4005 
395709239 PaOk Brisbane City 4005 
379716960 HaAm Brisbane City 4005 
255811828 RaMo Brisbane City 4007 
370058418 BrCl Brisbane North 4030 
394353072 DeWa Brisbane North 4030 
275130015 ChMa Brisbane North 4031 
352222085 GeTe Brisbane North 4032 
228004760 EiVe Brisbane North 4034 
465201563 JaCl Brisbane North 4034 
451496292 DeRo Brisbane North 4034 
337068637 ViSm Brisbane North 4035 
274807474 LeBe Brisbane South West 4077 
127195556 PeHu Brisbane City 4101 
255810003 RoDo Brisbane City 4101 
207238565 GrCl Brisbane South 4103 
328445213 GrCl Brisbane South 4103 
127198945 KaHa Brisbane South 4103 
431019367 AlSe Brisbane North 4104 
356665897 LuPe Brisbane South 4109 
468263113 AnVa Brisbane South 4110 
417675063 AnVa Brisbane South 4110 
328441086 BeSo Brisbane South East 4121 
483137851 DoPr Brisbane South East 4121 
328444903 BrHa Brisbane South East 4122 
420525523 PaGr Brisbane South East 4151 
461586782 PaGr Brisbane South East 4151 
228003390 JoSt Brisbane South East 4152 
274806508 PeDa Brisbane South East 4157 
328446127 SuBe Brisbane East 4159 
379715291 SuBe Brisbane East 4159 
329116087 PeHe Brisbane East 4160 
329119359 PeHe Brisbane East 4160 
272993344 PeFr Brisbane East 4172 
442989565 GoBl Brisbane East 4179 
206040847 GlKe Gold Coast 4207 
427761068 KeEc Gold Coast 4210 
385497420 PaRe Gold Coast 4211 
274804399 GiAv Gold Coast 4214 
29386800 GiOs Gold Coast 4214 
328449089 GiOs Gold Coast 4214 
465207950 GiOs Gold Coast 4214 
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218688812 NaSa Gold Coast 4215 
274808696 EiBr Gold Coast 4223 
427763392 EiBr Gold Coast 4223 
277121288 HaSo Brisbane South West 4301 
424022235 BeBo Brisbane South West 4301 
29388123 MiDa Brisbane South West 4305 
484665030 DaGo Brisbane South West 4305 
439710005 JaSh Brisbane South West 4340 
224345408 WiEl Toowoomba 4350 
228004023 LiMa Toowoomba 4350 
261241461 TaJe Toowoomba 4350 
312561032 GaWi Toowoomba 4352 
275135168 GaWi Toowoomba 4352 
320215986 GaWi Toowoomba 4352 
29387870 GeGo Western Queensland 4427 
228003224 MeLu Western Queensland 4455 
274241613 NoOw Western Queensland 4455 
379849661 ViCh Western Queensland 4455 
379714437 ViCh Western Queensland 4455 
328441105 JoCo Western Queensland 4455 
427766149 LeWh Western Queensland 4455 
427769475 MuAn Western Queensland 4455 
313939095 LeYo Brisbane North 4503 
465247398 RaGo Brisbane North 4508 
127194751 RoFI Brisbane North West 4520 
379713969 AlDo Sunshine Coast 4551 
383998336 ZoFu Sunshine Coast 4557 
398259809 AmWe Sunshine Coast 4562 
402734769 GrJo Sunshine Coast 4566 
486287283 GrJo Sunshine Coast 4566 
453520236 FrMc Sunshine Coast 4566 
336402419 DaMa Burnett Region 4610 
366610206 LaPe Central Queensland 4670 
425454927 NaKu Central Queensland 4680 
274800298 GaHa Central Queensland 4700 
255812452 LeWe North Queensland 4805 
275135278 IaRa North Queensland 4810 
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APPENDIX A2: DNA CONCENTRATIONS FOR ALL THE ISOLATES TESTED IN THIS STUDY. 
 
 
 
 
AUSLAB# 
Patient 
Name 
DNA 
Concentration 
(ng/µL) 
 
Sample Name 
DNA 
Concentration 
(ng/µL) 
395755535 PaOk  
12.1 
JK KITCHEN COLD +CPC RAISED BUFF 
YELLOW 
 
115.4 
395709239 PaOk  
20.1 
JK KITCHEN COLD +CPC RAISED BUFF 
YELLOW 
 
27.5 
379716960 HaAm  
15.2 
JK BATHROOM COLD +CPC ORANGE 
RAISED NM 
 
87.9 
255811828 RaMo  
36.2 
JK BATHROOM TAP B +CPC ORANGE 
RAISED NM 
 
86.1 
370058418 BrCl  
53.9 
JK SHOWER HOT +CPC YELLOW RAISED 
M 
 
125.1 
394353072 DeWa  
18.7 
JK SHOWER COLD +CPC YELLOW 
RAISED NM 
 
8.9 
275130015 ChMa  
8.6 
NW SHOWER COLD +CPC YELLOW BUFF 
FLAT 
 
34.7 
352222085 GeTe 34.6 MCG KITCHEN COLD WHITE FLAT BUFF 71.8 
228004760 EiVe  
27.5 
MCG KITCHEN COLD +CPC YELLOW 
RAISED 
 
24.1 
465201563 JaCl  
14.9 
MD AEROSOL PLATE CREAM FLAT BUFF 
- LIKE 
 
25.6 
451496292 DeRo 78.8 DP KITCHEN +CPC YELLOW RAISED M 39.8 
337068637 ViSm  
8.5 
DP BATHROOM COLD +CPC YELLOW 
FLAT BUFF 
 
36.7 
274807474 LeBe  
24.8 
DP SHOWER COLD +CPC YELLOW FLAT 
BUFF 
 
34.7 
127195556 PeHu  
26.3 
LYH1 SHOWER COLD OADC + PANTA 
XMGIT 9/9 
 
14.4 
255810003 RoDo 17.9 SP2 +CPC #1 91.3 
207238565 GrCl 47.4 SP2 +CPC #2 125.6 
328445213 GrCl 10.5 SP3 7H11 +CPC BUFF YELLOW 34.0 
127198945 KaHa 19.0 SP7 XMGIT? 8/8 16.6 
431019367 AlSe 11.3 SP18 +CPC 159.1 
356665897 LuPe 22.8 SP19 +CPC 13/6/07 10.6 
468263113 AnVa 18.5 SP24 +CPC 13/6/07 (11/7) 23.0 
417675063 AnVa 60.1 SP24 52.2 
328441086 BeSo 54.7 SP32 +CPC WHITE BUFF FLAT 30/8/07 17.6 
483137851 DoPr 22.3 SP32 O+C 29/8 17.5 
328444903 BrHa 8.7 SP33 O+P+C 4/9 144.2 
420525523 PaGr  
10.2 
SP33 +CPC WHITE LARGE FLAKY 20/6 
(SU) 
 
17.5 
461586782 PaGr 79.1 SP41 +CPC 14/6/07 (12/7) 45.6 
228003390 JoSt 37.3 SP49 96.3 
274806508 PeDa 19.4 SP57 +CPC 1/8/07 YELLOW FLAT BUFF 15.9 
328446127 SuBe 17.3 SP67 O+C 29/8 55.3 
379715291 SuBe 22.3 SP89 +PLATE 85.6 
329116087 PeHe 11.9 SP89 21/12 12.8 
329119359 PeHe 12.8 SP102 O+P 29/8 159.8 
272993344 PeFr 18.0 SP104 +CPC LARGE WHITE FLAT 20/6 23.1 
442989565 GoBl 39.8 SP104 O+P+C 5/8 90.9 
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AUSLAB# 
Patient 
Name 
DNA 
Concentration 
(ng/µL) 
 
Sample Name 
DNA 
Concentration 
(ng/µL) 
206040847 GlKe 7.7 SP105 +CPC 12/6/07 78.2 
427761068 KeEc 11.8 SP112 27.0 
385497420 PaRe 20.0 SP112 +CPC 12/4 32.5 
274804399 GiAv 10.6 SP119 +CPC FLAT LARGE 24.4 
29386800 GiOs 16.7 SP119 +CPC 14/06/07 (11/7) 32.4 
328449089 GiOs 21.4 SP127 XMGIT 5/8/07 (14/12) 11.8 
465207950 GiOs 15.7 SP147 O+P+C 4/9 10.8 
218688812 NaSa 32.5 SP152 +CPC LARGE BUFF #1 35.5 
274808696 EiBr 9.1 SP152 +CPC LARGE BUFF #2 64.4 
427763392 EiBr  
26.5 
SP154 +CPC CREAM/WHITE FLAT BUFF 
9/8/0 
 
8.9 
277121288 HaSo  
10.9 
SP155 +CPC WHITE/CREAM RAISED V 
BUFF 9/8/07 (30/11) 
 
60.3 
424022235 BeBo 20.3 SP155 +O 4/9 12.2 
29388123 MiDa 11.1 SP157 +CPC WHITE 31/7/07 (4/12) 22.4 
484665030 DaGo 22.3 SP157 WHITE 31/7/07 (4/12) 47.0 
439710005 JaSh 16.1 SP175 O+P+C 10/9 36.7 
224345408 WiEl 14.2 SP178 +CPC BUFF 22.9 
228004023 LiMa 16.2 SP142 O+P 5/9 22.1 
261241461 TaJe 21.4 SP183 +CPC WHITE 28/11 (14/12) 17.4 
312561032 GaWi  
9.7 
SP183 +CPC SMALLER YELLOW 28/11 
(14/12) 
 
46.5 
275135168 GaWi 11 SP217 +CPC CREAM FLAT M 7/8/07 12.4 
320215986 GaWi 23.8 SP218 WHITE 7/8/07 913/12) 9.4 
29387870 GeGo 27 SP251 +CPC X7H11 BUFF LARGE 16.3 
228003224 MeLu 12.8 SP260 +CPC WHITE FLAT BUFF 8/8/07 11.9 
274241613 NoOw 25.7 SP281 O+C 29/8 148.6 
379849661 ViCh 8.8 SP311 O+P+C 4/9 17.0 
379714437 ViCh 21.1   
328441105 JoCo 7.6   
427766149 LeWh 33.5   
427769475 MuAn 20.4   
313939095 LeYo 16.3   
465247398 RaGo 11.1   
127194751 RoFI 38.2   
379713969 AlDo 22.0   
383998336 ZoFu 8.2   
398259809 AmWe 12.8   
402734769 GrJo 16.4   
486287283 GrJo 11.2   
453520236 FrMc 24.9   
336402419 DaMa 13.6   
366610206 LaPe 8.2   
425454927 NaKu 18.3   
274800298 GaHa 85.4   
255812452 LeWe 15.4   
275135278 IaRa 10.2   
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APPENDIX A3: ENVIRONMENTAL WATER ISOLATES – *PLEASE SEE KEY BELOW TABLE FOR DEFINITIONS OF EACH 
COLUMN 
 
 
Plate 
Location* 
 
Sample Name* 
 
HaeIII* 
 
CfoI* 
 
DdeI* 
 
Strain 
Type* 
 
DiversiLab 
Pattern#* 
HRM 
Strain 
Match* 
Sequencing 
results for 16S 
rRNA* 
A1 JK KITCHEN COLD +CPC 
RAISED BUFF YELLOW 
No 
restriction 
pattern A pattern A V 3 No M. kansasii 
B1 JK KITCHEN COLD +CPC 
RAISED BUFF YELLOW 
No 
restriction 
No 
restriction 
pattern A I 27 No M. kansasii 
 
C1 
JK BATHROOM COLD 
+CPC ORANGE RAISED 
NM 
No 
restriction 
 
pattern A 
 
pattern A 
 
V 
 
3 
 
No 
 
M. kansasii 
 
D1 
JK BATHROOM TAP B 
+CPC ORANGE RAISED 
NM 
No 
restriction 
 
pattern A 
 
pattern A 
 
V 
 
3 
 
No 
 
M. kansasii 
E1 JK SHOWER HOT +CPC 
YELLOW RAISED M 
No 
restriction 
pattern A pattern A V 1 No M. kansasii 
F1 JK SHOWER COLD +CPC 
YELLOW RAISED NM 
No 
restriction 
pattern A pattern A V 3 No M. kansasii 
G1 NW SHOWER COLD +CPC 
YELLOW BUFF FLAT 
95,85,42 pattern A pattern A IV 16 No M. kansasii 
H1 MCG KITCHEN COLD 
WHITE FLAT BUFF 
No 
restriction 
pattern A pattern A V 11 No M. kansasii 
A2 MCG KITCHEN COLD 
+CPC YELLOW RAISED 
95,85,42 pattern A pattern A IV 14 No M. kansasii 
C2 MD AEROSOL PLATE 
CREAM FLAT BUFF - LIKE 
95,85,42 pattern A pattern A IV 16 No M. kansasii 
D2 
483137851 DP patient 
isolate 
No 
restriction 
pattern A pattern A V 28 No M. kansasii 
E2 DP KITCHEN +CPC 
YELLOW RAISED M 
No 
restriction 
pattern A pattern A V 3 No M. kansasii 
F2 DP BATHROOM COLD 
+CPC YELLOW FLAT BUFF 
No 
restriction 
pattern A pattern A V 7 No M. kansasii 
H2 DP SHOWER COLD +CPC 
YELLOW FLAT BUFF 
No 
restriction 
pattern A pattern A V 3 No M. kansasii 
 
A3 
LYH1 SHOWER COLD 
OADC + PANTA XMGIT 
9/9 
No 
restriction 
 
pattern A 
 
pattern A 
 
V 
 
2 
 
No 
 
M. kansasii 
B3 SP2 +CPC #1 No 
restriction 
pattern A pattern A V 4 No M. kansasii 
C3 SP2 +CPC #2 No 
restriction 
pattern A pattern A V 4 No M. kansasii 
D3 SP3 7H11 +CPC BUFF 
YELLOW 
No 
restriction 
pattern A pattern A V 1 No M. kansasii 
E3 SP7 XMGIT? 8/8 
No 
restriction 
pattern A pattern A V 9 No M. kansasii 
F3 SP18 +CPC No 
restriction 
pattern A pattern A V 5 No M. kansasii 
G3 SP19 +CPC 13/6/07 No 
restriction 
pattern A pattern A V 2 No M. kansasii 
H3 SP24 +CPC 13/6/07 
(11/7) 
No 
restriction 
pattern A pattern A V 3 No M. kansasii 
A4 SP24 No 
restriction 
pattern A pattern A V 3 No M. kansasii 
B4 SP32 +CPC WHITE BUFF 
FLAT 30/8/07 
95,85,42 pattern A pattern A IV 14 No M. kansasii 
C4 SP32 O+C 29/8 No restriction pattern A pattern A V 2 No M. kansasii 
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Plate 
Location* 
 
 
Sample Name* 
 
 
HaeIII* 
 
 
CfoI* 
 
 
DdeI* 
 
Strain 
Type* 
 
DiversiLab 
Pattern#* 
HRM 
Strain 
Match* 
Sequencing 
results for 16S 
rRNA* 
D4 SP33 O+P+C 4/9 95,85,42 pattern A pattern A IV 23 No M. kansasii 
E4 SP33 +CPC WHITE LARGE 
FLAKY 20/6 (SU) 
No 
restriction 
pattern A pattern A V 2 No M. kansasii 
F4 SP41 +CPC 14/6/07 
(12/7) 
No 
restriction 
pattern A pattern A V 3 No M. kansasii 
G4 SP49 95,85,42 pattern A pattern A IV 21 No M. kansasii 
H4 SP57 +CPC 1/8/07 
YELLOW FLAT BUFF 
95,85,42 pattern A pattern A IV 20 No M. kansasii 
A5 SP67 O+C 29/8 95,85,42 pattern A pattern A IV 15 No M. kansasii 
B5 SP89 +PLATE No 
restriction 
pattern A pattern A V 3 No M. kansasii 
C5 SP89 21/12 No 
restriction 
pattern A pattern A V 3 No M. kansasii 
D5 SP102 O+P 29/8 95,85,42 pattern A pattern A IV 16 No M. kansasii 
E5 SP104 +CPC LARGE 
WHITE FLAT 20/6 
95,85,42 pattern A pattern A IV 19 No M. kansasii 
F5 SP104 O+P+C 5/8 95,85,42 pattern A pattern A IV 16 No M. kansasii 
G5 SP105 +CPC 12/6/07 No 
restriction 
pattern A pattern A V** 12 No M. kansasii 
H5 SP112 No 
restriction 
pattern A pattern A V 2 No M. kansasii 
A6 SP112 +CPC 12/4 No 
restriction 
pattern A pattern A V 3 No M. kansasii 
B6 SP119 +CPC FLAT LARGE No 
restriction 
pattern A pattern A V 3 No M. kansasii 
C6 SP119 +CPC 14/06/07 
(11/7) 
No 
restriction 
pattern A pattern A V 4 No M. kansasii 
D6 
SP127 XMGIT 5/8/07 
(14/12) 
95,85,42 pattern A pattern A IV 17 No M. kansasii 
E6 SP147 O+P+C 4/9 No 
restriction 
pattern A pattern A V 3 No M. kansasii 
F6 SP152 +CPC LARGE BUFF 
#1 
No 
restriction 
pattern A pattern A V 3 No M. kansasii 
G6 SP152 +CPC LARGE BUFF 
#2 
No 
restriction 
pattern A pattern A V 3 No M. kansasii 
 
H6 
SP154 +CPC 
CREAM/WHITE FLAT 
BUFF 9/8/0 
No 
restriction 
 
pattern A 
 
pattern A 
 
V 
 
3 
 
No 
 
M. kansasii 
 
A7 
SP155 +CPC 
WHITE/CREAM RAISED V 
BUFF 9/8/07 (30/11) 
No 
restriction 
 
pattern A 
 
pattern A 
 
V 
 
2 
 
No 
 
M. kansasii 
B7 SP155 +O 4/9 No 
restriction 
pattern A pattern A V 10 No M. kansasii 
C7 SP157 +CPC WHITE 
31/7/07 (4/12) 
95,85,42 pattern A pattern A IV 16 No M. kansasii 
D7 SP157 WHITE 31/7/07 
(4/12) 
No 
restriction 
pattern A pattern A V 4 No M. kansasii 
F7 SP175 O+P+C 10/9 95,85,42 pattern A pattern A IV 17 No M. kansasii 
G7 SP178 +CPC BUFF No 
restriction 
pattern A pattern A V 4 No M. kansasii 
H7 SP142 O+P 5/9 No 
restriction 
pattern A pattern A V 18 No M. kansasii 
A8 SP183 +CPC WHITE 
28/11 (14/12) 
95,85,42 pattern A pattern A IV 15 No M. kansasii 
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Plate 
Location* 
 
 
Sample Name* 
 
 
HaeIII* 
 
 
CfoI* 
 
 
DdeI* 
 
Strain 
Type* 
 
DiversiLab 
Pattern#* 
HRM 
Strain 
Match* 
Sequencing 
results for 16S 
rRNA* 
B8 
SP183 +CPC SMALLER 
YELLOW 28/11 (14/12) 95,85,42 pattern A pattern A IV 22 No M. kansasii 
D8 SP217 +CPC CREAM FLAT 
M 7/8/07 
No 
restriction 
pattern A pattern A V 2 No M. kansasii 
E8 SP218 WHITE 7/8/07 
913/12) 
No 
restriction 
pattern A pattern A V 2 No M. kansasii 
F8 SP251 +CPC X7H11 BUFF 
LARGE 
No 
restriction 
pattern A pattern A V 8 No M. kansasii 
H8 SP260 +CPC WHITE FLAT 
BUFF 8/8/07 
No 
restriction 
pattern A pattern A V** 13 No M. kansasii 
A9 SP281 O+C 29/8 No 
restriction 
pattern A pattern A V 5 No M. kansasii 
B9 SP311 O+P+C 4/9 No 
restriction 
pattern A pattern A V 6 No M. kansasii 
C9 
M. KANSASII ATCC 12478 
POSITIVE CONTROL 
No 
restriction 
No 
restriction pattern A I 25 NA M. kansasii 
D9 M. KANSASII ATCC 12478 
POSITIVE CONTROL 
No 
restriction 
No 
restriction 
pattern A I 25 NA M. kansasii 
E9 M. KANSASII ATCC 12478 
POSITIVE CONTROL 
No 
restriction 
No 
restriction 
pattern A I 25 NA M. kansasii 
F9 NEGATIVE CONTROL        
*Key definitions of each identifier are as follows: 
 
 Plate Location – When the ITS-REA was first performed, each isolate was 
run once and had its own unique position in the 96well plate. This identifier 
corresponds to the position on the electrophoresis gel images as seen in the 
Appendix B: ITS-REA Enzyme Digest Gel Pictures. 
 Sample Name – identifier for that particular sample 
 
 HaeIII/Cfo1/Dde1 – ITS-REA enzyme result determined from the 
electrophoresis gel images; looking specifically at the characteristic banding 
pattern produced by each enzyme. 
 Strain type – the ITS-REA profile determined by the 3 enzyme digests. 
These were compared to (Roth et al. 1998) and a typical strain type was 
delegated. 
 DiversiLab Pattern # – the cluster number assigned by the DiversiLab 
software. The specific fingerprints created were aligned into a dendrogram 
and the isolates which were >97% in similarity were given the same pattern 
number. 
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 HRM Strain Match – comparison of each isolate to the M. kansasii ATCC 
strain and determined whether they were the same strain or a different 
strain. 
 Sequencing results for 16S rRNA  – 16S rRNA was performed on each 
isolate for two reasons: firstly to ensure the isolate was M. kansasii and it 
was pure and secondly the results were needed for the validation of HRM. 
 ** - the pattern from DiversiLab was very different to the other type V 
isolates suggesting a new novel species. 
APPENDIX A4: PATIENT ISOLATES – *PLEASE SEE KEY BELOW TABLE FOR DEFINITIONS OF EACH COLUMN 
Plate 
Location* 
 
AUSLAB#* 
Patient 
Name* 
 
HaeIII* 
 
CfoI* 
 
DdeI* 
Strain 
Type* 
DiversiLab 
Pattern#* 
HRM 
Strain 
Match* 
Sequencing 
results for 
16S rRNA* 
B1 127194751 RoFI No restriction No restriction pattern A I 3 No M. kansasii 
C1 127195556 PeHu No restriction No restriction pattern A I 4 No M. kansasii 
E1 207238565 GrCl No restriction No restriction pattern A I 8 No M. kansasii 
F1 328445213 GrCl No restriction No restriction pattern A I 3 No M. kansasii 
G1 206040847 GlKe No restriction No restriction pattern A I 7 No M. kansasii 
H1 228003224 MeLu No restriction No restriction pattern A I 7 No M. kansasii 
A2 224345408 WiEl No restriction No restriction pattern A I 2 No M. kansasii 
B2 228004023 LiMa No restriction No restriction pattern A I 4 No M. kansasii 
C2 228004760 EiVe No restriction No restriction pattern A I 3 Yes M. kansasii 
D2 255810003 RoDo No restriction No restriction pattern A I 3 No M. kansasii 
F2 255811828 RaMo 95,85,42 pattern A pattern A IV 37 No M. kansasii 
G2 127198945 KaHa 95,85,42 pattern A pattern A IV 34 No M. kansasii 
H2 255812452 LeWe No restriction No restriction pattern A I 3 No M. kansasii 
A3 272993344 PeFr No restriction No restriction pattern A I 2 No M. kansasii 
B3 277121288 HaSo No restriction No restriction pattern A I 3 No M. kansasii 
C3 261241461 TaJe No restriction No restriction pattern A I 1 No M. kansasii 
D3 274806508 PeDa No restriction No restriction pattern A I 1 No M. kansasii 
E3 228003390 JoSt 95,85,42 pattern A pattern A IV 33 No M. kansasii 
F3 274804399 GiAv No restriction No restriction pattern A I 1 No M. kansasii 
G3 29386800 GiOs No restriction No restriction pattern A I 2 No M. kansasii 
H3 328449089 GiOs No restriction No restriction pattern A I 2 No M. kansasii 
A4 465207950 GiOs No restriction No restriction pattern A I 6 No M. kansasii 
B4 274241613 NoOw No restriction No restriction pattern A I 6 No M. kansasii 
C4 275130015 ChMa No restriction No restriction pattern A I 19 No M. kansasii 
D4 274807474 LeBe No restriction pattern A pattern A V 24 No M. kansasii 
E4 275135278 IaRa No restriction No restriction pattern A I 6 Yes M. kansasii 
F4 274808696 EiBr No restriction pattern A pattern A V 26 No M. kansasii 
G4 427763392 EiBr No restriction pattern A pattern A V 29 No M. kansasii 
H4 312561032 GaWi No restriction No restriction pattern A I 1 No M. kansasii 
A5 275135168 GaWi No restriction No restriction pattern A I 3 No M. kansasii 
B5 320215986 GaWi No restriction No restriction pattern A I 3 No M. kansasii 
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C5 329116087 PeHe No restriction No restriction pattern A I 2 No M. kansasii 
D5 329119359 PeHe No restriction No restriction pattern A I 2 No M. kansasii 
E5 313939095 LeYo No restriction No restriction pattern A I 8 No M. kansasii 
F5 29387870 GeGo No restriction No restriction pattern A I 6 No M. kansasii 
G5 29388123 MiDa No restriction No restriction pattern A I 3 No M. kansasii 
A6 379849661 ViCh No restriction No restriction pattern A I 3 No M. kansasii 
B6 379714437 ViCh No restriction No restriction pattern A I 6 No M. kansasii 
C6 337068637 ViSm No restriction No restriction pattern A I 9 No M. kansasii 
D6 356665897 LuPe 95,85,42 pattern A pattern A IV 36 No M. kansasii 
E6 352222085 GeTe No restriction pattern A pattern A V 23 No M. kansasii 
F6 328441086 BeSo No restriction pattern A pattern A V 23 No M. kansasii 
G6 328441105 JoCo No restriction No restriction pattern A I 3 No M. kansasii 
H6 328444903 BrHa No restriction No restriction pattern A I 6 No M. kansasii 
A7 328446127 SuBe No restriction pattern A pattern A V 25 No M. kansasii 
B7 379715291 SuBe No restriction pattern A pattern A V 25 No M. kansasii 
C7 366610206 LaPe No restriction pattern A pattern A V 24 No M. kansasii 
D7 370058418 BrCl No restriction No restriction pattern A I 3 No M. kansasii 
F7 431019367 AlSe No restriction pattern A pattern A V 27 No M. kansasii 
G7 395755535 PaOk No restriction No restriction pattern A I 5 Yes M. kansasii 
H7 395709239 PaOk No restriction No restriction pattern A I 3 Yes M. kansasii 
A8 439710005 JaSh No restriction No restriction pattern A I 5 No M. kansasii 
B8 398259809 AmWe 95,85,42 pattern A pattern A IV 32 No M. kansasii 
C8 385497420 PaRe No restriction No restriction pattern A I 5 No M. kansasii 
D8 402734769 GrJo No restriction No restriction pattern A I 5 No M. kansasii 
E8 486287283 GrJo No restriction No restriction pattern A I 21 No M. kansasii 
F8 425454927 NaKu No restriction No restriction pattern A I 5 No M. kansasii 
G8 427761068 KeEc No restriction pattern A pattern A V 30 No M. kansasii 
H8 379713969 AlDo 95,85,42 pattern A pattern A IV 35 No M. kansasii 
A9 453520236 FrMc No restriction No restriction pattern A I 20 No M. kansasii 
B9 427766149 LeWh No restriction No restriction pattern A I 3 No M. kansasii 
C9 465201563 JaCl No restriction No restriction pattern A I 11 No M. kansasii 
D9 465247398 RaGo No restriction No restriction pattern A I 3 No M. kansasii 
E9 420525523 PaGr No restriction No restriction pattern A I 1 Yes M. kansasii 
F9 461586782 PaGr No restriction No restriction pattern A I 13 Yes M. kansasii 
G9 484665030 DaGo No restriction No restriction pattern A I 12 Yes M. kansasii 
H9 468263113 AnVa No restriction No restriction pattern A I 17 Yes M. kansasii 
A10 417675063 AnVa No restriction No restriction pattern A I 3 Yes M. kansasii 
C10 427769475 MuAn No restriction No restriction pattern A I 6 No M. kansasii 
D10 451496292 DeRo No restriction pattern A pattern A V 23 No M. kansasii 
E10 442989565 GoBl No restriction No restriction pattern A I 3 No M. kansasii 
F10 274800298 GaHa No restriction No restriction pattern A I 6 Yes M. kansasii 
G10 383998336 ZoFu No restriction No restriction pattern A I 10 Yes M. kansasii 
H10 218688812 NaSa No restriction No restriction pattern A I 7 No M. kansasii 
A11 336402419 DaMa No restriction No restriction pattern A I 14 Yes M. kansasii 
B11 424022235 BeBo No restriction No restriction pattern A I 15 Yes M. kansasii 
C11 379716960 HaAm No restriction No restriction pattern A I 16 Yes M. kansasii 
D11 394353072 DeWa No restriction No restriction pattern A I 2 Yes M. kansasii 
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E11 
 M. KANSASII 
ATCC 12478 
POSITIVE 
CONTROL 
 
No restriction 
 
No restriction 
 
pattern A 
 
I 
 
18 
 
NA 
 
M. kansasii 
 
F11 
 M. KANSASII 
ATCC 12478 
POSITIVE 
CONTROL 
 
No restriction 
 
No restriction 
 
pattern A 
 
I 
 
18 
 
NA 
 
M. kansasii 
H11  NEGATIVE 
CONTROL 
       
*Key definitions of each identifier are as follows: 
 
 Plate Location – When the ITS-REA was first performed, each isolate was 
run once and had its own unique position in the 96well plate. This identifier 
corresponds to the position on the electrophoresis gel images as seen in the 
Appendix B: ITS-REA Enzyme Digest Gel Pictures. 
 Auslab # - a unique code that is used to identify and monitor patient 
samples in the Pathology Queensland. 
 Patient Name – patient isolates that have been de-identified. 
 
 HaeIII/Cfo1/Dde1 – ITS-REA enzyme result determined from the 
electrophoresis gel images; looking specifically at the characteristic banding 
pattern produced by each enzyme. 
 Strain type – the ITS-REA profile determined by the 3 enzyme digests. 
These were compared to (Roth et al. 1998) and a typical strain type was 
delegated. 
 DiversiLab Pattern # – the cluster number assigned by the DiversiLab 
software. The specific fingerprints created were aligned into a dendrogram 
and the isolates which were >97% in similarity were given the same pattern 
number. 
 HRM Strain Match – comparison of each isolate to the M. kansasii ATCC 
strain and determined whether they were the same strain or a different 
strain. 
 Sequencing results for 16S rRNA – 16S rRNA was performed on each 
isolate for two reasons: firstly to ensure the isolate was M. kansasii and it 
was pure and secondly the results were needed for the validation of HRM. 
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Appendix B: ITS-REA Enzyme Digest Gel Pictures 
 
ITS Primer Trial with different thermal cycling conditions 
 
 
 
ITS Primary Amplification product check – Patient 
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ITS Primary Amplification product check – Water 
 
 
 
HaeIII – Patient Gel 1 
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HaeIII – Patient Gel 2 
 
 
 
HaeIII – Patient Gel 3 
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HaeIII – Patient Gel 4 
 
 
 
HaeIII – Patient Gel 5 
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HaeIII – Patient Gel 6 & Water Gel 5 
 
 
 
HaeIII – Water Gel 1 
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HaeIII – Water Gel 2 
 
 
 
HaeIII – Water Gel 3 
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HaeIII – Water Gel 4 
 
 
 
CfoI – Patient Gel 1 
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Cfo1 – Patient Gel 2 
 
 
 
Cfo1 – Patient Gel 3 
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Cfo1 – Patient Gel 4 
 
 
 
Cfo1 – Patient Gel 5 
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Cfo1 – Patient Gel 6 & Water Gel 5 
 
 
 
Cfo1 – Water Gel 1 
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Cfo1 – Water Gel 2 
 
 
 
Cfo1 – Water Gel 3 
 
 
 
Cfo1 – Water Gel 4 
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Dde1 – Patient Gel 1 
 
 
 
 
Dde1 – Patient Gel 2 
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Dde1 – Patient Gel 3 
 
 
 
 
 
 
 
Dde1 – Patient Gel 4 
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Dde1 – Patient Gel 5 
 
 
 
 
 
 
 
 
Dde1 – Patient Gel 6 & Water Gel 5 
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Dde1 – Water Gel 1 
 
 
 
 
 
Dde1 – Water Gel 2 
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Dde1 – Water Gel 3 
 
 
 
Dde1 – Water Gel 4 
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HaeIII & Cfo1 – Repeat Gel 
 
 
 
 
Dde1 – Repeat Gel 
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Appendix C: DiversiLab Results from bioMerieux software printout 
 
DiversiLab Patient Results 
 
 
 
Fingerprint Dendrogram 
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Fingerprint Dendrogram continued 
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Fingerprint Dendrogram 
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Fingerprint Dendrogram continued 
108 
Molecular analysis of Mycobacterium kansasii from human and potable water specimens 108 
 
 
 
 
 
 
Fingerprint Dendrogram continued 
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Scatterplot of Patient results 
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DiversiLab Water Results 
 
 
Fingerprint Dendrogram 
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Fingerprint Dendrogram 
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Fingerprint Dendrogram continued 
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Fingerprint Dendrogram continued 
 
 
Scatterplot of Water isolates 
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Appendix D: HRM Results 
In this Appendix, all HRM results are listed below.  
Screenshots from Rotor-Gene Q Series Software 
For the Normalised graphs below: Y – Axis is the Normalised Fluorescence and X – 
axis is the Melting Temperature in degrees Celsius. 
For the Difference graphs below: Y – Axis is the Normalised Fluorescence minus the 
Reference Strain and X – axis is the Melt Temperature in degrees Celsius where the 
strain deviates from the Reference strain. 
Run 1 – Normalised graph – Patient isolates 
 
 
Run 1 – Difference Graph – Patient isolates 
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Run 2 – Normalised Graph – Patient isolates 
 
 
Run 2 – Difference Graph – Patient isolates 
 
 
Run 3 – Normalised Graph – Water isolates 
 
 
116 
Molecular analysis of Mycobacterium kansasii from human and potable water specimens 116 
 
 
 
 
Run 3 – Difference Graph – Water isolates 
 
 
Run 4 – Normalised Graph – Water isolates 
 
 
Run 4 – Difference Graph – Water isolates 
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Run 5 – Normalised Graph – Patient isolates 
 
 
Run 5 – Difference Graph – Patient isolates 
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Run 6 – Normalised Graph – repeats from previous failed samples, both Patient and 
Water isolates 
 
 
 
Run 6 – Difference Graph – repeats from previous failed samples, both Patient and 
Water isolates 
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Clustal W Analysis Screenshots from BioEdit 
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Figtree Dendrograms from 16S rRNA Sequences 
 
 
 
Top circle = Strain type V; Middle circle = Strain type IV; Bottom circle = Strain type I 
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Appendix E: DNA Sequencing Protocol 
 
DNA Sequencing for Identification 
1 Purpose 
This method describes the procedure for amplification and sequencing of 
16S rRNA and hsp65 gene fragments from presumptive Mycobacterium and 
aerobic Actinomycetes isolates. These sequences can then be searched 
against databases to provide an identification for the isolate. 
 
 
2 Scope 
This document is for use by staff of the Queensland Mycobacterium 
Reference Laboratory who have a background in molecular biology and who 
meet the requirements of the PCR suite. 
 
This method relies on partial sequencing of genes rather than sequencing 
complete genes. The partial regions used are sufficient for discrimination of 
mycobacterium due to the conserved nature of these regions amongst 
species5. As such, this method is only intended to be used for identification 
or exclusion of mycobacterium and Nocardia species. 
 
3 Principle 
16S rRNA Sequencing 
 
Transcription of the 16S rRNA produces the small rRNA sub unit of the 
bacterial ribosome. The ribosomal structure is essential for bacterial function 
and is highly conserved amongst bacteria. However there are hypervariable 
regions within the gene that can vary without affecting the ribosomal 
structure. These regions are often detectably different between species and 
can serve as a tool to classify and identify organisms. 
Using UNEX primers to amplify a 500bp region from a cultured isolate, the 
product is then cleaned and sequenced on an ABI Prism 3730DNA sequencer 
(Applied Biosystems)1. Sequences are then compared against a database 
(most often NCBI public database) to identify similar or identical sequences. 
Phenotypic information about an isolate is also considered together with the 
database search results when forming an identification. 
 
hsp65 Sequencing 
 
The protein encoded by hsp65 is another conserved region suitable as a 
target for the identification of bacteria, in particular Mycobacteria. 
Amplification of a 440bp fragment using PCR with target specific primers are 
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followed by product purification and sequencing as mentioned above. 
Sequences are then compared against a database (most often NCBI public 
database) to identify similar or identical sequences. Phenotypic information 
about an isolate is also considered together with the database search results 
when forming an identification. 
 
4 Definitions 
hsp65-Heat shock protein that is 65 kilodaltons in molecular weight 
PCR -Polymerase Chain Reaction 
16S rRNA-Gene for 16S Ribosomal RNA 
bp-Base Pair 
NCBI-National Center for Biotechology Information 
 
 
5 Requirements 
5.1 Reagents 
Qiagen 10 X PCR buffer + Magnesium chloride reagent 
Qiagen dNTP mix 
Taq polymerase 
Agarose gel powder 
1X TAE electrophoresis buffer 
Ethidium bromide 
EXOSAP-IT 
6X loading dye and 100bp DNA Ladder in Loading Dye 
Big Dye Terminator Mix 
5x Sequencing buffer 
Molecular Grade Water 
Trigene disinfectant 
Invitrogen Bufferless-gel (96-well) platform 
 
16S Sequencing Primers 
Sequencing Primer BF 5’-GTAAAACGACGGCCAGTAGAGTTGGATCCTGGCTCAG-3’ 
Sequencing Primer R2 5’-CCTACGAGCTCTTTACG-3 
 
Hsp-65 Sequencing Primers 
Sequencing Primer hsp65F (A11) 
5’- GTAAAACGACGGCCAGTACC AAC GAT GGT GTG TCC AT - 3` 
Sequencing Primer hsp65R (A12) 5’- CTTGTCGAACCGCATACCCT -3 
 
 
5.2 Equipment 
96-well PCR plate & PCR lids 
PCR racks 
Vortex mixer 
Microcentrifuge 
Thermal Cycler 
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Microcentrifuge tubes, 1.5ml conical Variable 
pipettes and plugged disposable tips 
Invitrogen 2% Agarose gel cassettes 
Invitrogen Mother Base for 96-well cassettes 
 
6 Safety 
The majority of the tasks performed in these PCR methods are carried out in 
the PCR Suite on Level 4. The integrity of the workspaces within PCR Suite 
is dependent upon unidirectional airflow and strict observation of guidelines 
(QIS 24964). 
Staff must have participated in a PCR suite induction session before working 
in the PCR Suite and procedures must be carried out in dedicated 
workspaces in PCR Suite using the allocated equipment only. Correct 
Personal Protective Equipment (PPE) must be used. 
Warning: Ethidium bromide is a teratogen. Nitrile gloves need to be worn 
while handling this chemical and caution is advised. 
 
 
7 Sampling and Sample Preparation 
Pure isolate of the test organism is required for sequencing work. 
For DNA template preparation see QIS# 17626 
 
8 Procedure 
1 In  Auslab,  review  the  patients  on  the  Mycobacteria  for  rRNA  Seq 
Workflow List (MYCSEQ) and print. 
2 Obtain the DNA from storage (e.g. from PC2 fridge # 
RBR.B07.L05.RM062.FRT2) 
3 Fill in patient details and number of tests being performed including a 
positive and negative control (see Appendix 1 DNA Sequencing For 
Identification Worksheet) 
4 Save the worksheet under the current M: and year file pathway and 
print. 
5 Book sufficient thermal cyclers for the test. 
 
8.1 Mastermix Preparation (Primary PCR) 
1 Remove reagents from freezer and allow them to thaw. 
2 Record lot numbers and expiry dates on worksheet. 
3 Prepare a working dNTP dilution (1:10) as well as the primers (BF & R2 
or hsp65F (A11) & hsp65R (A12) at a (1:10) dilution. 
4 Vortex reagent tubes well. 
5 Label a 96-well plate for the Primary Amplification with the date. 
6 Prepare the master mix in a sterile microcentrifuge tube. Vortex well. 
7 Dispense 48µl aliquots of the master mix into each well of the primary 
amplification plate and close the plate with 8-strip PCR caps. 
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8 Return  reagents  to  freezer  storage  and  disinfectant  work  area  and 
record on decontamination log (QIS 25291) 
 
 
8.2 DNA Addition: (PCR Loading Room) 
1 Add 2µl of the DNA template to the wells in the PCR plate containing 
primary amplification master mix corresponding to the order on the 
worksheet. 
2 Disinfectant work area and record on decontamination log. 
 
8.3 Primary PCR: DNA Amplification 
1 Turn on thermal cycler and locate programme in user file MRL (Seq 
Primary). 
2 Thermal cycler conditions are: 
94°C 5mins1 cycle 
 
94°C 1min 
55°C 1min  35 cycles 
72°C 1min 
 
72°C  10min 1 cycle 
15°C Soak 
 
8.4 Primary PCR: PCR Product Check 
Refer to QIS# 18899 
1 Prepare the required number of electrophoresis baths with 1X TAE 
buffer. 
2 Prepare the number of 2% electrophoresis gels with 1X TAE and 3µl 
Ethidium bromide required for both the Primary Amplification and 
Product Purification. 
3 Dispense 2µl aliquots of 6X gel loading dye onto Parafilm for all samples 
including the Negative control. 
4 Add 8µl primary PCR product to the 6X gel loading dye and mix gently. 
5 Transfer 10µl mixture to a well in the gel. 
6 Load the first and last well with 5µl 100bp DNA Ladder. 
7 Electrophorese the samples for 40mins at 100V / constant Amp. 
8 Transfer gel to the Bio-Rad GelDoc system. If Primary Amplification PCR 
has been successful, intense bands for each test sample and the Positive 
control well  will be  evident  at  about 500bp  (16S) and  about  440bp 
(hsp65), and there will be no product band in the negative control lane. 
9 Photograph gel using GelDoc and also save a copy onto the following 
path on M:\MRL\Sequencing. 
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8.5 Primary PCR: Product Purification 
1 Using a new 96 well plate, dispense 4µl of EXOSAP-IT into sufficient 
wells for each PCR reaction with product. Samples that have no 
product, e.g.: negative control, have no further work performed on 
them. 
2 Add 10µl of Primary Amplification PCR product to the corresponding 
wells of the plate. 
3 Put the plate in thermal cycler. Find folder “MRL” and choose 
program “exosap”. 
Thermal cycler conditions are: 
37°C 15 min 
80°C 15 min 
4°C soak 
 
8.6 Product Purification: PCR Product Check 
1 Use the Invitrogen Bufferless gel system: using the 8-channell Multi- 
channel pipette, place 5µL of the purified product into each well. Do not 
add Loading dye.  Once this is done turn on the Mother Base and set the 
time for 5 mins, press START. When the 5 mins has elapsed, press the 
START button to stop the gel running. 
2 Photograph gel using GelDoc and also save a copy onto the following 
path on M:\MRL\Sequencing. 
3 Store the purified product at 0-4°C if required that day, or at -20°C until 
required. 
 
8.7 Sequencing PCR Reaction Set -up 
1 Complete preparation of the sequencing Mastermix by adding Big Dye 
Terminator and Sequencing Buffer (see Appendix 1). 
2 Label a 96-well plate with the code “_<initials of person performing 
test>_< date of submission in yyyy/mm/dd format>, for example: if 
operator with initials AA is submitting a plate on the first of June 2013 – 
AA_20130601. 
3 Dispense 9µl of the Mastermix and 0.5µl of purified product to the 
corresponding wells of the plate and seal plate. 
4 Return reagents to freezer storage and wipe bench with Trigene 
disinfectant and record on decontamination log (QIS#: 25291). 
 
 
8.8 Sequencing PCR: DNA Amplification 
1 Select the program “seq” under the MRL folder on the thermal cycler. 
The thermal cycling conditions are: 
30 cycles of 
95°C 20sec 
50°C 15sec 
60°C   60sec 
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2 Using Sequencing submission sheet (QIS#: 25291), complete the 
spreadsheet with required data and following the prompts email the 
sheet to the Sequencing Service. 
 
 
9 Calculations and Results 
9.1 Calculations and Results – Mycobacteria species 
1. Sequence results can be found at 
M:\Sequencing_Service\Sequencing_Data\MRL_2014 
2. The Sequencing service provides a report on the quality of each sequence. 
Sequences must meet the following requirements MM18-A : 
a.Average QV>20 
b.>300bp useable sequence 
c.Signal:noise > 100:1 
d.< 0.5% ambiguous base calls 
3. Open the NCBI homepage: https://www.ncbi.nlm.nih.gov and sign in under 
QMRL with NCBI Username : pathmrl 
4. Open the nucleotide BLAST platform 
5. Add sequential sample sequences in FASTA format to the Query Sequence 
window. 
a. Cut and paste location/AUSLAB numbers to identify each sequence. 
b.Visualise each sequence using appropriate software, e.g. Finch TV 
c.Clean sequence before pasting into BLAST e.g.: remove primer 
sequences, adjust ambiguous base calls 
6. Run the BLAST search using “Others (nr etc.)” as the Database Search Set with 
Program Selection optimized for “Highly similar sequences (megablast)”. 
7. Once the BLAST results are available, open the “Recent Results” tab and save 
the run as a “Saved Strategies”. 
8. Return to the BLAST results and open the Sequencing for Identification 
worksheet (Appendix 1) in another window. 
9. Record each samples sequencing identification in the worksheet. For guides 
on interpreting BLAST results, see the following: 
a.BLAST 
b.MM18-A5 
10. Review results for each patient with regards to patient history, culture 
morphology, time of growth etc. Any conflicting information may need 
investigation and a supervisor should be consulted. 
11. Ensure that the rest of the worksheet is completed and product check gel 
photos are attached. 
12. At this stage the results should be checked with another scientist for correct 
transcription and interpretation. The other scientist should confirm: 
a. The run meets quality criteria 
b. Correct identifications have been recorded on the worksheet(check 
BLAST results) 
c. Identifications fit with other information 
d. Reagent QC and product check information is complete 
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e. The worksheet is signed off 
13.After the worksheet is checked, enter the results into AUSLAB specimen 
notes, recording the region sequenced, the identification and the 
percentage match for each result i.e.: either 100%, 99% or <99% 
14.Enter the organism identification on the “Tests for Mycobacteria” page. 
15.Further tests may be required, e.g.: sequencing of another region, 
morphology check. If this is the case, add the appropriate test code/ worklist 
code. 
16. If no further tests are required, delete the “Further tests are being carried 
out” comment and replace with the appropriate comment. Ie: either 
“susnp\” or “tind\” shortcuts. 
17. Ensure each specimen page has the MYCOID code added. 
18. Ensure each specimen page has the “mtf1\” short cut entered in the last 
field of the page. 
19. If the report for a specimen is complete, validate all “AFB” pages except the 
main page, then add to the MYCSIGN list. The report is then reviewed by the 
Chief Scientist before being released. 
20. Remove the entry from the MYSEQ list 
 
 
9.2 Calculations and Results – Nocardia species 
1. Sequence analysis is performed as for Mycobacteria species. Follow steps 
9.1.1 – 9.1.13. Entering the results for Nocardia species into AUSLAB is 
different to Mycobacterium results mainly because of the lack of an AFB 
code (and hence AFB pages) for these results. 
2. Each presumptive Nocardia should have a “SITE” code and associated AUSLAB 
page. Enter the identification into an available organism field on this page. If 
the correct organism is not listed in AUSLAB, it may be necessary to type the 
result into the comment field and enter Nocardia sp. in the organism field. 
3. All Nocardia sp have an identification and sensitivities performed. Ensure that 
each Nocardia is on either the MYCNOC (sensitivities to be performed) or 
the MYCACT (sensitivities already performed) lists. 
4. Nocardia results are reviewed by a PC3 staff member before being sent to the 
MYCSIGN list. 
5. Remove each entry from the MYCSEQ list. 
 
 
10 Method Performance 
When reporting the results, the following criteria should be followed: 
 The identification is only accepted when the percentage match from 
the sequence is ≥99%. 
 If it is less than this (i.e. ≤98%), the identification can only be given as 
M. species. 
 If an unusual Mycobacterium is identified by sequencing, the details 
are entered into AUSLAB specimen notes. Taking into account all the 
details e.g. clinical history, site of isolate and morphological features. 
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Refer to Chief Scientist or supervisor. If the isolate is considered an 
environmental organism and not known to cause disease, it is also 
called M. species. 
 
 
11 Quality Controls and Acceptance Criteria 
Results are valid if the: 
 Positive Control is Positive – Positive control used are M. 
intracellulare (ATCC 13950) for 16S and M. abscessus (ATCC 19977) 
for hsp65 
 Negative Control is Negative – Negative control used a reaction blank 
to rule out any source of contamination within the reagents used. 
 
 
12 Reporting 
After results are entered in to AUSLAB, the report is reviewed by the QMRL 
Chief Scientist before being released. The clinical relevance of the organism 
identification is not commented on in the laboratory report; however each 
report provides information on how to contact the Clinical Microbiologist for 
further information. 
 
 
13 Records 
The  Sequencing  Service  maintains  a  permanent  electronic  record  of  all 
sequence files. 
Electronic copies of worksheets are kept at “M:\MRL\Sequencing” for the 
current year while worksheet hardcopies are kept for a minimum of three 
years in the QMRL bookshelf. 
Patient  records  are  maintained  on  AUSLAB  by  the  Health  Services 
Information Agency. 
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Appendix F: Dubos Broth Media Recipe 
 
Dubos Broth 
PURPOSE 
Universal broth culture medium for Mycobacteria. 
 
 
INGREDIENTS Storage Amount 
Dubos Broth base (Difco 238510) RT 3.25g 
Rabbit Serum -200C 50mL 
Glycerol (Ajax 242-2.5GL) RT 25mL 
RO water  425mL 
 
pH: 6.6 0.2 
 
PREPARATION 
1. Add the Glycerol and the Dubos Broth base to the RO water and mix 
well. 
2. Autoclave 121°C for 15 min. 
3. Cool to approximately 50°C in a water bath. 
4. Add the Rabbit Serum and mix thoroughly. 
5. Dispense in 2mL amounts into 7mL sterile plastic bottles. 
6. Label DUBOS include the expiry date. 
 
HAZARDS 
Dubos Broth base: Irritant 
 
SHELF LIFE 
The prepared medium may be stored for up to 3 months at 2-8°C. 
 
QUALITY CONTROL 
M fortuitum ATCC 6841 (58446-0605) producing turbid Growth. 
M.intracellulare ATCC 15985 (58446-0584) producing turbid Growth. 
REFERENCES 
Difco & BBL Manual: Manual of Microbiological Culture Media (Second 
Edition - 2009). 
